NZ715250B2 - Plant extract containing diketopiperazine and method for producing same - Google Patents
Plant extract containing diketopiperazine and method for producing same Download PDFInfo
- Publication number
- NZ715250B2 NZ715250B2 NZ715250A NZ71525014A NZ715250B2 NZ 715250 B2 NZ715250 B2 NZ 715250B2 NZ 715250 A NZ715250 A NZ 715250A NZ 71525014 A NZ71525014 A NZ 71525014A NZ 715250 B2 NZ715250 B2 NZ 715250B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- cyclo
- plant
- phe
- pro
- extract
- Prior art date
Links
- 239000000419 plant extract Substances 0.000 title claims abstract description 53
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical compound O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 title claims description 35
- 244000269722 Thea sinensis Species 0.000 claims abstract description 138
- 241000196324 Embryophyta Species 0.000 claims abstract description 102
- 239000000284 extract Substances 0.000 claims abstract description 99
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 44
- 244000068988 Glycine max Species 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 31
- XWYXUMDVQIOAPR-UWVGGRQHSA-N cyclo(L-leucyl-L-leucyl) Chemical compound CC(C)C[C@@H]1NC(=O)[C@H](CC(C)C)NC1=O XWYXUMDVQIOAPR-UWVGGRQHSA-N 0.000 claims abstract description 29
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 11
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 10
- AGYQRUGEOWASSY-LBPRGKRZSA-N (2s)-2-[(1-aminocyclopentanecarbonyl)amino]-3-phenylpropanoic acid Chemical compound N([C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)C1(N)CCCC1 AGYQRUGEOWASSY-LBPRGKRZSA-N 0.000 claims abstract description 7
- 108010049311 cycloleucylleucine Proteins 0.000 claims abstract description 7
- 244000000231 Sesamum indicum Species 0.000 claims abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 107
- 102000004190 Enzymes Human genes 0.000 claims description 73
- 108090000790 Enzymes Proteins 0.000 claims description 73
- 108091005804 Peptidases Proteins 0.000 claims description 48
- 235000018102 proteins Nutrition 0.000 claims description 45
- 102000004169 proteins and genes Human genes 0.000 claims description 45
- 108090000623 proteins and genes Proteins 0.000 claims description 45
- 239000004365 Protease Substances 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 34
- 238000000354 decomposition reaction Methods 0.000 claims description 33
- 238000010438 heat treatment Methods 0.000 claims description 29
- 235000020712 soy bean extract Nutrition 0.000 claims description 24
- 235000021118 plant-derived protein Nutrition 0.000 claims description 10
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 108010044940 alanylglutamine Proteins 0.000 claims description 8
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 6
- 229960002648 alanylglutamine Drugs 0.000 claims description 4
- 229940069780 barley extract Drugs 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 235000013616 tea Nutrition 0.000 abstract description 134
- 239000000796 flavoring agent Substances 0.000 abstract description 23
- 235000019634 flavors Nutrition 0.000 abstract description 23
- 235000013305 food Nutrition 0.000 abstract description 22
- 238000013461 design Methods 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract 2
- 239000005445 natural material Substances 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 description 70
- 238000000605 extraction Methods 0.000 description 60
- 102000004196 processed proteins & peptides Human genes 0.000 description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 49
- 102000035195 Peptidases Human genes 0.000 description 47
- 239000000243 solution Substances 0.000 description 38
- 235000019419 proteases Nutrition 0.000 description 35
- 239000000203 mixture Substances 0.000 description 26
- JUAPMRSLDANLAS-HOTGVXAUSA-N cyclo(L-phenylalanyl-L-phenylalanyl) Chemical compound C([C@@H]1NC([C@@H](NC1=O)CC=1C=CC=CC=1)=O)C1=CC=CC=C1 JUAPMRSLDANLAS-HOTGVXAUSA-N 0.000 description 23
- 108010039669 cyclo(phenylalanyl-phenylalanyl) Proteins 0.000 description 23
- JUAPMRSLDANLAS-UHFFFAOYSA-N cyclo-L-Phe-L-Phe Natural products O=C1NC(CC=2C=CC=CC=2)C(=O)NC1CC1=CC=CC=C1 JUAPMRSLDANLAS-UHFFFAOYSA-N 0.000 description 23
- IFQZEERDQXQTLJ-NSHDSACASA-N Cyclo(glycyltryptophyl) Chemical compound N1C(=O)CNC(=O)[C@@H]1CC1=CNC2=CC=CC=C12 IFQZEERDQXQTLJ-NSHDSACASA-N 0.000 description 22
- 235000019658 bitter taste Nutrition 0.000 description 22
- XWYXUMDVQIOAPR-UHFFFAOYSA-N (3S,6S)-3,6-Diisobutyl-2,5-dioxohexahydropyrazine Natural products CC(C)CC1NC(=O)C(CC(C)C)NC1=O XWYXUMDVQIOAPR-UHFFFAOYSA-N 0.000 description 21
- BZUNCDPEEKFTCX-GJZGRUSLSA-N (3s,6s)-3-(1h-indol-3-ylmethyl)-6-(2-methylpropyl)piperazine-2,5-dione Chemical compound N1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CC1=CNC2=CC=CC=C12 BZUNCDPEEKFTCX-GJZGRUSLSA-N 0.000 description 21
- QPDMOMIYLJMOQJ-UHFFFAOYSA-N Cyclo-L-leu-L-phe Natural products N1C(=O)C(CC(C)C)NC(=O)C1CC1=CC=CC=C1 QPDMOMIYLJMOQJ-UHFFFAOYSA-N 0.000 description 19
- QPDMOMIYLJMOQJ-STQMWFEESA-N cyclo(L-phenylalanyl-L-leucyl) Chemical compound N1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CC1=CC=CC=C1 QPDMOMIYLJMOQJ-STQMWFEESA-N 0.000 description 19
- 108010048344 cyclo(leucyl-phenylalanyl) Proteins 0.000 description 19
- BKASXWPLSXFART-UHFFFAOYSA-N 1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1',2'-f]pyrazine-5,10-dione Chemical compound O=C1C2CCCN2C(=O)C2CCCN12 BKASXWPLSXFART-UHFFFAOYSA-N 0.000 description 18
- QZBUWPVZSXDWSB-UHFFFAOYSA-N 3'-Acetamido-3'-deoxyadenosin Natural products O=C1N2CCCC2C(=O)NC1CC1=CC=CC=C1 QZBUWPVZSXDWSB-UHFFFAOYSA-N 0.000 description 18
- WWISPHBAYBECQZ-IMJSIDKUSA-N (3s,6s)-3,6-dimethylpiperazine-2,5-dione Chemical compound C[C@@H]1NC(=O)[C@H](C)NC1=O WWISPHBAYBECQZ-IMJSIDKUSA-N 0.000 description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 17
- SZJNCZMRZAUNQT-IUCAKERBSA-N cyclo(L-Leu-L-Pro) Chemical compound O=C1[C@H](CC(C)C)NC(=O)[C@@H]2CCCN21 SZJNCZMRZAUNQT-IUCAKERBSA-N 0.000 description 17
- 108010038252 cyclo(phenylalanyl-prolyl) Proteins 0.000 description 17
- SZJNCZMRZAUNQT-UHFFFAOYSA-N (3R,8aS)-hexahydro-3-(2-methylpropyl)pyrrolo[1,2-a]pyrazine-1,4-dione Natural products O=C1C(CC(C)C)NC(=O)C2CCCN21 SZJNCZMRZAUNQT-UHFFFAOYSA-N 0.000 description 16
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 16
- 241000209094 Oryza Species 0.000 description 16
- 108010015607 cyclo(alanylalanyl) Proteins 0.000 description 16
- WWISPHBAYBECQZ-UHFFFAOYSA-N cyclo-L-Ala-L-Ala Natural products CC1NC(=O)C(C)NC1=O WWISPHBAYBECQZ-UHFFFAOYSA-N 0.000 description 16
- 108010027501 cyclo(leucyl-prolyl) Proteins 0.000 description 15
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 14
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 13
- -1 se M Proteins 0.000 description 12
- UBLWFFBGMBRBMC-VQVTYTSYSA-N (3S,8aS)-3-[(1R)-1-hydroxyethyl]-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1[C@H]([C@H](O)C)NC(=O)[C@@H]2CCCN21 UBLWFFBGMBRBMC-VQVTYTSYSA-N 0.000 description 12
- ZJDMXAAEAVGGSK-ROUUACIJSA-N (3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)piperazine-2,5-dione Chemical compound C1=CC(O)=CC=C1C[C@H]1C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N1 ZJDMXAAEAVGGSK-ROUUACIJSA-N 0.000 description 12
- VNHJXYUDIBQDDX-UWVGGRQHSA-N 2-[(2s,5s)-5-benzyl-3,6-dioxopiperazin-2-yl]acetic acid Chemical compound N1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CC1=CC=CC=C1 VNHJXYUDIBQDDX-UWVGGRQHSA-N 0.000 description 12
- NAKUGCPAQTUSBE-IUCAKERBSA-N cyclo(L-His-L-Pro) Chemical compound C([C@@H]1NC([C@@H]2CCCN2C1=O)=O)C1=CN=CN1 NAKUGCPAQTUSBE-IUCAKERBSA-N 0.000 description 12
- ZJDMXAAEAVGGSK-UHFFFAOYSA-N cyclo-L-Trp-L-Phe Natural products C1=CC(O)=CC=C1CC1C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)N1 ZJDMXAAEAVGGSK-UHFFFAOYSA-N 0.000 description 12
- 108010017068 histidyl-proline diketopiperazine Proteins 0.000 description 12
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 12
- 239000002994 raw material Substances 0.000 description 12
- VQFHWKRNHGHZTK-LURJTMIESA-N (3s)-3-(2-methylpropyl)piperazine-2,5-dione Chemical compound CC(C)C[C@@H]1NC(=O)CNC1=O VQFHWKRNHGHZTK-LURJTMIESA-N 0.000 description 11
- UZOJHXFWJFSFAI-VIFPVBQESA-N (3s)-3-benzylpiperazine-2,5-dione Chemical compound N1C(=O)CNC(=O)[C@@H]1CC1=CC=CC=C1 UZOJHXFWJFSFAI-VIFPVBQESA-N 0.000 description 11
- HLXXMJDWTBXTOR-STQMWFEESA-N (3s,6s)-3-benzyl-6-(1h-imidazol-5-ylmethyl)piperazine-2,5-dione Chemical compound C([C@@H]1NC([C@@H](NC1=O)CC=1NC=NC=1)=O)C1=CC=CC=C1 HLXXMJDWTBXTOR-STQMWFEESA-N 0.000 description 11
- PNSKRAHOHQWAAN-WHFBIAKZSA-N 3-[(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]propanamide Chemical compound C[C@@H]1NC(=O)[C@H](CCC(N)=O)NC1=O PNSKRAHOHQWAAN-WHFBIAKZSA-N 0.000 description 11
- LSGOTAXPWMCUCK-UHFFFAOYSA-N D-prolyl-L-tyrosine anhydride Natural products C1=CC(O)=CC=C1CC1C(=O)N2CCCC2C(=O)N1 LSGOTAXPWMCUCK-UHFFFAOYSA-N 0.000 description 11
- 108010048643 cyclo(aspartyl-phenylalanyl) Proteins 0.000 description 11
- 108010046166 cyclo(glycyltryptophyl) Proteins 0.000 description 11
- 108010021250 cyclo(leucylglycine) Proteins 0.000 description 11
- 108010012664 cyclo(seryltyrosyl) Proteins 0.000 description 11
- LSGOTAXPWMCUCK-RYUDHWBXSA-N maculosin Chemical compound C1=CC(O)=CC=C1C[C@H]1C(=O)N2CCC[C@H]2C(=O)N1 LSGOTAXPWMCUCK-RYUDHWBXSA-N 0.000 description 11
- CHYMARRIVIIBNV-UWVGGRQHSA-N (3S,6S)-3-(4-Hydroxybenzyl)-6-(hydroxymethyl)-2,5-piperazinedione Chemical compound N1C(=O)[C@H](CO)NC(=O)[C@@H]1CC1=CC=C(O)C=C1 CHYMARRIVIIBNV-UWVGGRQHSA-N 0.000 description 10
- WIJKWEYCUNYTGY-UWVGGRQHSA-N (3s,6s)-3-benzyl-6-(hydroxymethyl)piperazine-2,5-dione Chemical compound N1C(=O)[C@H](CO)NC(=O)[C@@H]1CC1=CC=CC=C1 WIJKWEYCUNYTGY-UWVGGRQHSA-N 0.000 description 10
- OWOHLURDBZHNGG-YFKPBYRVSA-N (8ar)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1CNC(=O)[C@@H]2CCCN12 OWOHLURDBZHNGG-YFKPBYRVSA-N 0.000 description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- UZOJHXFWJFSFAI-SECBINFHSA-N cyclic glycylphenylalanine Natural products N1C(=O)CNC(=O)[C@H]1CC1=CC=CC=C1 UZOJHXFWJFSFAI-SECBINFHSA-N 0.000 description 10
- 150000004885 piperazines Chemical class 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- QGMAWEIDGADSAC-YUMQZZPRSA-N (3s,6s)-3,6-di(propan-2-yl)piperazine-2,5-dione Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C(C)C)NC1=O QGMAWEIDGADSAC-YUMQZZPRSA-N 0.000 description 9
- VFVAGPWBFWJBMN-YUMQZZPRSA-N (3s,8as)-3-(2-methylsulfanylethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1[C@H](CCSC)NC(=O)[C@@H]2CCCN21 VFVAGPWBFWJBMN-YUMQZZPRSA-N 0.000 description 9
- WSLYCILIEOFQPK-UHFFFAOYSA-N 3-methyl-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1C(C)NC(=O)C2CCCN21 WSLYCILIEOFQPK-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- QGMAWEIDGADSAC-UHFFFAOYSA-N L-Valyl-L-valine anhydride Natural products CC(C)C1NC(=O)C(C(C)C)NC1=O QGMAWEIDGADSAC-UHFFFAOYSA-N 0.000 description 9
- 241000209140 Triticum Species 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- 108010001140 cyclo(glycylprolyl) Proteins 0.000 description 9
- 108010023968 cyclo(prolylprolyl) Proteins 0.000 description 9
- WIJKWEYCUNYTGY-UHFFFAOYSA-N cyclo-L-Phe-L-Ser Natural products N1C(=O)C(CO)NC(=O)C1CC1=CC=CC=C1 WIJKWEYCUNYTGY-UHFFFAOYSA-N 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- CUVKAUWOMPJEMI-ROUUACIJSA-N (11S,14S)-Cyclo-(L-Trp-L-Phe) Chemical compound C([C@@H]1NC([C@@H](NC1=O)CC=1C2=CC=CC=C2NC=1)=O)C1=CC=CC=C1 CUVKAUWOMPJEMI-ROUUACIJSA-N 0.000 description 8
- VSOISORJHNBTCV-YUMQZZPRSA-N (3s,6s)-3,6-bis(2-methylsulfanylethyl)piperazine-2,5-dione Chemical compound CSCC[C@@H]1NC(=O)[C@H](CCSC)NC1=O VSOISORJHNBTCV-YUMQZZPRSA-N 0.000 description 8
- 108090000145 Bacillolysin Proteins 0.000 description 8
- 102000035092 Neutral proteases Human genes 0.000 description 8
- 108091005507 Neutral proteases Proteins 0.000 description 8
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- 108010056243 alanylalanine Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- WSLYCILIEOFQPK-WDSKDSINSA-N cis-Cyclo[L-Ala-L-Pro] Chemical compound O=C1[C@H](C)NC(=O)[C@@H]2CCCN21 WSLYCILIEOFQPK-WDSKDSINSA-N 0.000 description 8
- 235000019710 soybean protein Nutrition 0.000 description 8
- DEFJQIDDEAULHB-IMJSIDKUSA-N L-alanyl-L-alanine Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(O)=O DEFJQIDDEAULHB-IMJSIDKUSA-N 0.000 description 7
- 241000207961 Sesamum Species 0.000 description 7
- 238000009835 boiling Methods 0.000 description 7
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 7
- 108010077112 prolyl-proline Proteins 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 108010016626 Dipeptides Proteins 0.000 description 6
- 108010059378 Endopeptidases Proteins 0.000 description 6
- 102000005593 Endopeptidases Human genes 0.000 description 6
- LNCFUHAPNTYMJB-IUCAKERBSA-N His-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNCFUHAPNTYMJB-IUCAKERBSA-N 0.000 description 6
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 6
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 6
- 235000010724 Wisteria floribunda Nutrition 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 108010085325 histidylproline Proteins 0.000 description 6
- 108010057821 leucylproline Proteins 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 5
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 5
- WEQJQNWXCSUVMA-RYUDHWBXSA-N Phe-Pro Chemical compound C([C@H]([NH3+])C(=O)N1[C@@H](CCC1)C([O-])=O)C1=CC=CC=C1 WEQJQNWXCSUVMA-RYUDHWBXSA-N 0.000 description 5
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 108010087924 alanylproline Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 238000002203 pretreatment Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- JBCLFWXMTIKCCB-VIFPVBQESA-N Gly-Phe Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-VIFPVBQESA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 4
- LCPYQJIKPJDLLB-UWVGGRQHSA-N Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C LCPYQJIKPJDLLB-UWVGGRQHSA-N 0.000 description 4
- DZMGFGQBRYWJOR-YUMQZZPRSA-N Met-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O DZMGFGQBRYWJOR-YUMQZZPRSA-N 0.000 description 4
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 4
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 4
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 4
- GVUVRRPYYDHHGK-VQVTYTSYSA-N Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 GVUVRRPYYDHHGK-VQVTYTSYSA-N 0.000 description 4
- KRNYOVHEKOBTEF-YUMQZZPRSA-N Val-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O KRNYOVHEKOBTEF-YUMQZZPRSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000013353 coffee beverage Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- 108010081551 glycylphenylalanine Proteins 0.000 description 4
- 108010077515 glycylproline Proteins 0.000 description 4
- 108010084389 glycyltryptophan Proteins 0.000 description 4
- 108010092114 histidylphenylalanine Proteins 0.000 description 4
- 108010091798 leucylleucine Proteins 0.000 description 4
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 4
- 108010051242 phenylalanylserine Proteins 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 108010021889 valylvaline Proteins 0.000 description 4
- 108091005508 Acid proteases Proteins 0.000 description 3
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 3
- AJHCSUXXECOXOY-NSHDSACASA-N Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-NSHDSACASA-N 0.000 description 3
- XMAUFHMAAVTODF-STQMWFEESA-N His-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 XMAUFHMAAVTODF-STQMWFEESA-N 0.000 description 3
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 3
- BQVUABVGYYSDCJ-ZFWWWQNUSA-N Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-ZFWWWQNUSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 3
- JMCOUWKXLXDERB-WMZOPIPTSA-N Phe-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 JMCOUWKXLXDERB-WMZOPIPTSA-N 0.000 description 3
- OIDKVWTWGDWMHY-RYUDHWBXSA-N Pro-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 OIDKVWTWGDWMHY-RYUDHWBXSA-N 0.000 description 3
- 101710180012 Protease 7 Proteins 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- TYYLDKGBCJGJGW-WMZOPIPTSA-N Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 TYYLDKGBCJGJGW-WMZOPIPTSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 3
- 108010079317 prolyl-tyrosine Proteins 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010044292 tryptophyltyrosine Proteins 0.000 description 3
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 240000006439 Aspergillus oryzae Species 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- 241000228257 Aspergillus sp. Species 0.000 description 2
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 2
- BCVIOZZGJNOEQS-XKNYDFJKSA-N Ile-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)[C@@H](C)CC BCVIOZZGJNOEQS-XKNYDFJKSA-N 0.000 description 2
- 102100034866 Kallikrein-6 Human genes 0.000 description 2
- 101710138460 Leaf protein Proteins 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- QZBUWPVZSXDWSB-RYUDHWBXSA-N cyclo(L-Phe-L-Pro) Chemical compound C([C@@H]1NC([C@@H]2CCCN2C1=O)=O)C1=CC=CC=C1 QZBUWPVZSXDWSB-RYUDHWBXSA-N 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- GKZIWHRNKRBEOH-UHFFFAOYSA-N phenylalanylphenylalanine Chemical compound C=1C=CC=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 GKZIWHRNKRBEOH-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000020339 pu-erh tea Nutrition 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 235000020138 yakult Nutrition 0.000 description 2
- XKSXNQDBYZUQHG-QMMMGPOBSA-N (2s)-1-(1-aminocyclopentanecarbonyl)pyrrolidine-2-carboxylic acid Chemical compound N1([C@@H](CCC1)C(O)=O)C(=O)C1(N)CCCC1 XKSXNQDBYZUQHG-QMMMGPOBSA-N 0.000 description 1
- MSOMFHPQDYWNEZ-ZETCQYMHSA-N (2s)-1-cyclopropylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C1CC1 MSOMFHPQDYWNEZ-ZETCQYMHSA-N 0.000 description 1
- HLXXMJDWTBXTOR-UHFFFAOYSA-N 3-benzyl-6-(1h-imidazol-5-ylmethyl)piperazine-2,5-dione Chemical compound O=C1NC(CC=2NC=NC=2)C(=O)NC1CC1=CC=CC=C1 HLXXMJDWTBXTOR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000981399 Aspergillus melleus Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 241000729876 Niveus Species 0.000 description 1
- JLNTWVDSQRNWFU-UHFFFAOYSA-N OOOOOOO Chemical compound OOOOOOO JLNTWVDSQRNWFU-UHFFFAOYSA-N 0.000 description 1
- RTYZCUMXOXNVSI-UHFFFAOYSA-N OOOOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOOOO RTYZCUMXOXNVSI-UHFFFAOYSA-N 0.000 description 1
- ZMAKCCXIFPCMEE-UHFFFAOYSA-N OOOOOOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOOOOOO ZMAKCCXIFPCMEE-UHFFFAOYSA-N 0.000 description 1
- RRCYYLHJWRYWEI-UHFFFAOYSA-N OOOOOOOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOOOOOOO RRCYYLHJWRYWEI-UHFFFAOYSA-N 0.000 description 1
- RXJRSPBZRVRVLM-UHFFFAOYSA-N OOOOOOOOOOOOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOOOOOOOOOOOO RXJRSPBZRVRVLM-UHFFFAOYSA-N 0.000 description 1
- LXEPVHXXBMDAQC-UHFFFAOYSA-N OOOOOOOOOOOOOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOOOOOOOOOOOOO LXEPVHXXBMDAQC-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000235545 Rhizopus niveus Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 108010076347 cyclo(prolyl-leucyl) Proteins 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 108010007119 flavourzyme Proteins 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000020347 goishicha tea Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- ZYTPOUNUXRBYGW-UHFFFAOYSA-N methionyl-methionine Chemical compound CSCCC(N)C(=O)NC(C(O)=O)CCSC ZYTPOUNUXRBYGW-UHFFFAOYSA-N 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 108010043535 protease S Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 235000020046 sherry Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000004724 ultra fast liquid chromatography Methods 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Abstract
The present invention provides plant extracts, specifically tea, soybean, barley, and sesame extracts, that comprise at least one diketopiperazine(s) at a concentration of 10 µg/100 g/Bx or more, and that have a total concentration of diketopiperazines per Bx of 900 µg/100g/Bx or more. The invention further provides methods of obtaining plant extracts that comprise cyclo-leucyl-leucine and cyclo-leucyl-phenylalanine by means of high-temperature (100°C-170°C) and high-pressure (0.101-0.79MPa) for 30 to 500 minutes. The plant extracts obtained are superior in terms of their plant-based natural-substance derived flavour. As the extracts contain a large content of diketopiperazines and maintain a low Bx, the amount added to food and/or beverages may be low, which is advantageous in that it enables an increased degree of freedom in the design of food and/or drink. further provides methods of obtaining plant extracts that comprise cyclo-leucyl-leucine and cyclo-leucyl-phenylalanine by means of high-temperature (100°C-170°C) and high-pressure (0.101-0.79MPa) for 30 to 500 minutes. The plant extracts obtained are superior in terms of their plant-based natural-substance derived flavour. As the extracts contain a large content of diketopiperazines and maintain a low Bx, the amount added to food and/or beverages may be low, which is advantageous in that it enables an increased degree of freedom in the design of food and/or drink.
Description
DESCRIPTION
PLANT T CONTAINING DIKETOPIPERAZINE AND
METHOD FOR PRODUCING SAME
TECHNICAL FIELD
The present invention s to a plant extract
containing a high concentration of a diketopiperazine and a
method for producing the extract.
BACKGROUND ART
"Dipeptides", which are each composed of two amino
acids bonded to each other, have been paid attention as
functional substances. Dipeptides can be provided with
physical ties or novel functions that are not possessed
by simple amino acids and are expected as materials having
application ranges broader than those of amino acids. In
particular, diketopiperazines, which are cyclic dipeptides,
are known to have various physiological activities, such as an
antibacterial action or an antioxidant action (Non Patent
Literatures 1 and 2) and a learning motivation—improving
action (Patent Literature 1), and demands for
diketopiperazines are predicted to increase in the l and
pharmacological fields.
In general, a piperazine is produced by, for
e, chemical synthesis (Non Patent Literature 3) or an
enzymatic method (Non Patent Literatures 2 and 4). In
addition, a method of synthesizing a cyclic peptide having an
ary amino acid sequence by a dehydration and cyclization
reactions of a linear peptide in water of high—temperature and
high—pressure of a ritical or tical region (Patent
Literature 2) and a method of producing a cyclic dipeptide by
heat treatment of a linear dipeptide or linear tripeptide in
an aqueous solvent (Patent Literatures 3 and 4) have been
proposed.
CITATION LIST
PATENT LITERATURE
Patent Literature 1: National Publication of
ational Patent Application No. 2012—517998
Patent Literature 2: Japanese Patent Laid—Open No. 2003—
252896
Patent Literature 3: Korean Patent Laid—Open No. 10—2011—
0120051
Patent Literature 4: Japanese Patent No. 5456876
Patent Literature 5: Japanese Patent Laid—Open No. 2010—
166911
Patent Literature 6: National Publication of
International Patent Application No. 2012—517214
NON PATENT LITERATURE
Non Patent Literature 1: Peptides, 16(1), 151—164
(1995)
Non Patent Literature 2: Bioscience & Industry, 60(7),
454—457 (2002)
Non Patent Literature 3: J. Comb. Chem., 3, 453—460
(2001)
Non Patent Literature 4: try Biology, 8, 997—1010
(2001)
Non Patent ture 5: Agr. Biol. Chem., 38(5), 927—932
(1974)
SUMMARY OF INVENTION
TECHNICAL PROBLEM
Although piperazines are thus expected to show
various physiological activities in vivo, there are almost no
naturally derived diketopiperazines and foods containing high
concentrations of diketopiperazines. Naturally d
diketopiperazines are known to be present in fermented foods,
such as sherry, Shaoxing wine, soy sauce, sweet cooking rice
wine, and vinegar (Non Patent Literature 5), but the contents
n are significantly low. In order to take these foods
for obtaining the functionality of the piperazines,
considerably large amounts of the foods must be taken. Thus,
none of them is practical. Coffee drinks containing
Cyclo(Pro—Phe) or Cyclo(Pro—Leu) are also known (Patent
Literature 5), but these diketopiperazines are highly bitter
and are therefore difficult to be applied to other drinks.
Furthermore, compositions ning relatively
large amounts of diketopiperazines derived from animal protein,
such as collagen and meat, are known (Patent Literatures 4 and
6). However, because of their flavor, the compositions
containing these piperazines derived from animal protein
cannot be ly mixed with drinks mainly composed of
extracts .C
or juices o_ plants, such as tea drinks, coffee
drinks, soybean drinks, and fruit juice drinks, or soft drinks,
such as flavored water, mineral water, and carbonated drinks.
It is an object of the present invention to provide
an extract ning a naturally derived and highly safe
diketopiperazine at a high concentration and having good
flavor and to provide a method for producing the extract.
SOLUTION TO M
The present inventors, who have diligently studied
for solving the mentioned problems, have found that a
plant extract containing a high concentration of a
diketopiperazine can be produced by subjecting a protein-
containing plant to decomposition treatment to generate plant
peptides and subjecting the plant es to high—temperature
and high—pressure treatment in a liquid. The inventors have
confirmed that this plant extract has a good taste, and have
arrived at the completion of the present invention.
The present invention relates to the ing
aspects:
(1) A plant extract containing at least one of cyclo—
alanyl—glutamine, alanyl—alanine, cyclo—seryl-tyrosine,
cyclo-glycyl—leucine, cyclo—glycyl—tryptophan, cyclo—valyl—
valine, cyclo—tryptophanyl-tyrosine, cyclo—leucyl—tryptophan,
and cyclo~phenylalanyl—phenylalanine at a concentration of
ug/lOO g/Bx or more;
(2) The plant extract according to aspect (1), wherein
the total amount of diketopiperazine(s) per Ex is
900 ug/lOO g/Bx or more;
(3) The plant extract according to aspect (l) or (2),
being a tea t, a soybean extract, or a malt extract;
(4) A plant extract prepared by subjecting a protein—
ning plant to decomposition treatment to generate a
plant peptide and subjecting the plant peptide to high—
temperature and high-pressure treatment in a liquid;
(5) A method for producing a plant extract containing a
high concentration of piperazines including cycloleucyl-leucine
and cyclo-leucyl-phenylalanine, the method
comprising a step of subjecting a plant peptide to mperature
and high-pressure treatment in a liquid;
(6) The method according to aspect (5), wherein the hightemperature
and ressure treatment is performed in a
liquid of 100°C to 170°C for from 30 minutes to several hours
as heating conditions;
(7) The method according to aspect (5) or (6), wherein
the plant peptide is an oligopeptide;
(8) The method according to any one of aspects (5) to
(7), wherein the plant peptide is prepared by subjecting a
plant-derived protein or a protein-containing plant to
decomposition ent;
(9) The method according to aspect (8), wherein the
decomposition treatment is heat ent or enzyme treatment;
(10) The method according to aspect (9), n the
decomposition treatment is enzyme treatment, and the enzyme is
an endo-type protease.
In a particular aspect, the present invention provides a
plant extract comprising at least one of cyclo-alanylglutamine
, alanyl-alanine, cyclo-seryl-tyrosine, cycloglycyl-leucine
, cyclo-glycyl-tryptophan, cyclo-valyl-valine,
[FOLLOWED BY PAGE 5a]
- 5a -
cyclo-tryptophanyl-tyrosine, cyclo-leucyl-tryptophan, cyclophenylalanyl-proline
, and cyclo-phenylalanyl-phenylalanine at
a concentration of 10 μg/100 g/Bx or more, wherein the plant
extract is a tea extract, a soybean extract, a barley extract,
or a sesame extract, and the total amount of
diketopiperazine(s) per Bx is 900 μg/100 g/Bx or more.
In another particular aspect, the present invention
provides a method for producing a plant t containing a
high concentration of diketopiperazines including cycloleucyl-leucine
and cyclo-leucyl-phenylalanine, the method
comprising a step of subjecting a plant peptide to a treatment
at 100°C to 170°C and 0.101 to 0.79 MPa for 30 to 500 minutes
in a , wherein the plant peptide is a tea peptide, a
soybean peptide, a barley peptide, or a sesame peptide.
ADVANTAGEOUS EFFECTS OF INVENTION
According to the present invention, a plant t
containing a high tration of a naturally d and
highly safe diketopiperazine can be simply produced in a mass
production scale t requiring a troublesome process or
complicated facilities.
[FOLLOWED BY PAGE 6]
BRIEF DESCRIPTION OF DRAWINGS
Fig. I shows the results of quantitative measurement
of cyclo-phenylalanyl—phenylalanine concentration in a plant
peptide—processed product prepared from soybean protein.
Fig. 2 shows the results of quantitative measurement of
cyclo—phenylalanyl—phenylalanine concentration in a plant
e—processed product prepared from rice n.
Fig. 3 shows a relationship between the number of times
of pre-extraction and the l rate of the soluble
component.
DESCRIPTION OF EMBODIMENTS
(Plant peptide)
The plant extract of the present invention can be
produced by subjecting plant peptides to high—temperature and
high—pressure treatment in a liquid. Herein, the term "plant
peptide" refers to a peptide composed of l amino acids
linked by depolymerization (oligopeptide formation) of a
plant—derived protein or a protein—containing plant through
known decomposition treatment (e.g., decomposition treatment
with heat or pressure, osition ent with an acid or
alkali, or decomposition treatment with an enzyme), unless
otherwise specified.
:0014] The plant peptide of the present invention can be,
“or example, a n peptide, a barley peptide, a wheat
e, a wheat germ peptide, a pea peptide, or a rice
peptide. As described below, the plant peptide may be
prepared from a plant—derived protein or a protein~containing
plant or may be a commercial product. Examples of the
commercially available plant peptide include soybean peptides,
such as HINUTE AM, HINUTE DC, and HINUTE HK (all manufactured
by Fuji Oil Co., Ltd.); rice es, such as Oryza Peptide
P60 (manufactured by Oryza Oil & Fat al Co., Ltd.);
wheat peptides, such as Glutamine Peptide GP—lN and Glutamine
e GP-N (both manufactured by Nisshin Pharma Inc.); and
sesame peptides, such as Sesame Peptide KM-ZO (manufactured by
KISCO Ltd. ) .
The examinations by the present inventors
demonstrate that the yield of a diketopiperazine mixture
varies depending on the sizes of the peptides. The plant
peptides preferably include a high proportion of peptides
having a molecular weight of 5000 or less, more preferably a
molecular weight of 3000 or less, and particularly preferably
a molecular weight of 1000 or less. In on, since the
use of soybean having a high amino acid score allows
generation of multiple types of diketopiperazines at a high
concentration, soybean peptides are one of preferred
ments.
The plant peptide of the present invention can be a
peptide mixture produced using a plant—derived protein or a
protein—containing plant as a raw material. Specifically,
examples of the peptide mixture e those produced by
known decomposition treatment (e.g., decomposition treatment
with heat or pressure, decomposition treatment with an acid or
alkali, or decomposition ent with an enzyme) of a raw
material: a plant*derived n, such as soybean protein,
wheat protein, wheat germ protein, rice protein, or sesame
protein; or an edible protein—containing plant, such as a leaf
(e.g., green tea leaves), a seed (e.g., barley, wheat, malt,
sesame, or rice), a bean (e.g., soybean, adzuki bean, or black
soybean), a potato (e.g., sweet potato or potato). Among
these protein—containing plants, n, malt, and tea leaves
are preferably used in the t invention. In particular,
soybean and tea leaves are preferably used, and tea leaves are
more preferably used. Decomposition treatment is applied to
the above—mentioned plant—derived protein or the protein-
containing plant as a raw material to prepare a peptide
e, which is used as the plant peptide. This
osition ent is performed under conditions allowing
generation of oligopeptides. Specifically, the decomposition
treatment is performed so as to se the proportion of
peptides having a molecular weight of 5000 or less (preferably
a molecular weight of 3000 or less and more preferably a
molecular weight of 1000 or less).
The decomposition treatment is preferably performed
with heat and/or an enzyme because of the easiness (high
reaction rate) of generation of an intended oligopeptide and
easiness of mass treatment. In particular, decomposition
treatment with an enzyme (hereinafter, referred to as enzyme
treatment) is preferably employed.
The decomposition treatment by heating is performed
in a solvent for ting the plant or n from being
burned. The amount of the solvent is usually about 10 to 100
parts by mass, preferably about 15 to 80 parts by mass, more
preferably about 20 to 60 parts by mass, and particularly
preferably about 20 to 40 parts by mass based on 1 part by
mass of the plant. The solvent is preferably, for example,
water, ethanol, or a mixture thereof and particularly
ably water. The heating may be performed under any
ions that allow generation of peptides. Examples of the
g conditions include heating at 100°C or more and
further at 125°C or more for 30 minutes to l hours,
preferably about 2 to 7 hours. As the heat treatment
equipment, for example, a pressure cooker or an autoclave can
be used depending on the heating conditions. This heat
treatment can be performed simultaneously with the "step of
high—temperature and high—pressure treatment in a " of
the present ion.
In the production of plant peptides by the enzyme
treatment, the enzyme used is a proteolytic enzyme (protease)
and is preferably a protease having a high endo—type
decomposition ty. The protease is roughly classified
into three categories: alkaline protease, neutral protease,
and acid protease, based on the difference in optimum pH for
the action. In addition, the origin of a protease is a plant
origin, an animal origin, or a microbial origin. The enzyme
may have any origin and optimum pH that do not cause
disadvantageous influences, such as low decomposition
efficiency or bad flavor of the resulting decomposition
extract.
Examples of the bacterial protease that can be used
in the present ion include Protease N, Protease NL,
Protease S, and Proleather (R) FG—F (all manufactured by Amano
_lO_
Enzyme Inc.); Protin NY, Protin P, Deskin, Depirays, Protin A,
and Thermoase (R) (all manufactured by Daiwa Fine Chemicals
Co., Ltd.); Bioplase (R) XL—416F, Bioplase (R) SP—4FG, and
Bioplase (R) SP—lBFG (all ctured by Nagase ChemteX
Corporation); Orientase (R) 9ON, Nucleicin (R), Orientase (R)
lONL, and Orientase (R) 22BF (all manufactured by HBI Enzymes
Inc.); Aloase (R) AP-lO (manufactured by Yakult Pharmaceutical
[Industry Co., Ltd.); Protamex (R), Neutrase (R), and Alcalase
(R) (all manufactured by mes Japan Ltd.); COROLASE N,
COROLASE 7089, VERON W, and VERON P (all manufactured by AB
Enzymes); Enchiron NBS (manufactured by Rakuto Kasei
Industrial Co., Ltd.); and Alkali Protease GL440, Purafect (R)
4000L, Protease 899, and Protex 6L (all ctured by
Genencor Kyowa Co., Ltd.). Examples of aspergillus se
that can be used in the present invention include Protease A,
se M, Protease P, Umamizyme, Peptidase R, Newlase (R) A,
and Newlase (R) F (all manufactured by Amano Enzyme Inc.);
Sumizyme (R) AP, Sumizyme (R) LP, Sumizyme (R) MP, Sumizyme
(R) PP, and Sumizyme (R) LPL (all manufactured by Shinnihon
als Corporation); Protin (R) FN (manufactured by Daiwa
Fine Chemicals Co., Ltd.); Denapsin 2P, Denazyme (R) AP, and
XP—415 (all manufactured by Nagase ChemteX Corporation);
Orientase (R) 20A, Orientase (R) CNS, and Tetrase (R) 8 (all
manufactured by HBI Enzymes Inc.); Molsin (R) F, PD , IP
Enzyme, and AO—Protease (all manufactured by Kikkoman
Corporation); Sakanase (manufactured by Kaken Pharma Co.,
Ltd.); Pantidase (R) YP-SS, Pantidase (R) NP—Z, and Pantidase
(R) P (all manufactured by Yakult Pharmaceutical Industry Co.,
-11..
Ltd.); Flavourzyme (R) (manufactured by Novozymes Japan Ltd.);
se (R) SS and Kokulase (R) P (both manufactured by
Mitsui Lifetech Co., Ltd.); and VERON PS and COROLASE PN-L
(both manufactured by AB Enzymes). es of other
proteases that can be used in the present invention include
actinomycete proteases (for example, se (R) AS and
Actinase (R) AF (both manufactured by Kaken Pharma Co., Ltd.);
and Tasinase (R) (manufactured by or Kyowa Co., Ltd.));
plant—derived proteases (for example, Papain W-40
(manufactured by Amano Enzyme Inc.), food—grade purified
Papain (manufactured by Nagase ChemteX ation)); and
animal pepsin and trypsin.
Among the above-mentioned proteases, from the
viewpoint of the decomposition efficiency and the flavor of
the resulting peptide—containing solution, the protease is
preferably a bacterial protease, more ably a neutral
protease derived from Bacillus subtilis or a protease derived
from Bacillus amyloliquefaciens or Bacillus stearothermophilus,
and particularly preferably a neutral protease derived from
Bacillus subtilis.
Such a protease is used in an amount within a range
of 0.1% to 20% by weight, preferably 1% to 15% by weight, more
preferably 3% to 10% by weight, based on the amount of the
plant—derived protein or the protein—containing plant. An
amount less than the above—mentioned range cannot provide the
effect of increasing the yield of peptide generation, whereas
an amount higher than the mentioned range cannot achieve
a considerable increase in the yield of e generation,
-12_
which is disadvantageous in the cost. In the enzyme treatment,
water is added to a plant—derived protein or a plant to allow
the enzyme to act on the wetted protein or plant. The amount
of water to be added is y about 10 to 50 parts by mass,
more preferably about 10 to 30 parts by mass, and particularly
preferably about 10 to 20 parts by mass, based on 1 part by
mass of the dry protein or plant.
The conditions for the enzyme treatment by a
protease may be determined in view of the optimum conditions
for the protease and are usually at 20°C to 70°C (preferably
°C to 60°C and more preferably 40°C to 60°C) for about 30 min
to 24 hours (preferably 1 to 12 hours and more ably 1 to
6 hours).
Since the sites of the actions of enzymes on protein
as a substrate are ent based on the types of the s,
the composition of the diketopiperazine mixture prepared by
the present invention can be varied. ingly, the enzyme
can be selected in View of the composition of a desired
diketopiperazine mixture. Two or more enzymes may be used in
combination.
When a plant is used as plant es, pretreatment
for reducing the amount of water—soluble protein contained in
the plant is preferably performed before the step of
generating peptides by the above—described decomposition
treatment. The examinations by the present inventors
demonstrate that the reduction in the water—soluble protein in
advance considerably increases the yield of peptides ted
by decomposition treatment or the yield of diketopiperazines
-13..
generated by the heat treatment of the present invention.
Examples of the pretreatment for removing water—soluble
prptein include a method in which soluble protein is
eluted by heating a plant in a liquid, solid—liquid separation
is performed to collect the solid (plant), and the solid is
decomposed and a method in which a plant is ted to
extraction treatment with an aqueous solvent, such as water,
and the extraction residue is then decomposed (hereinafter,
these methods are tively referred to as "pre—
tion"). In the pre—extraction, a plant is immersed in
an extracting solvent of which the weight is ably about
times or more, more preferably about 15 to 150 times, the
weight of the plant, and the soluble component, such as water—
soluble protein, contained in the plant are eluted. In this
case, the extracting solvent may be heated in advance.
Alternatively, a plant is ed in an ting solvent
and the solvent may be then heated for extraction. The
extracting solvent is preferably pure water and may be pure
water appropriately containing an organic solvent, such as
ethanol. The ting solvent may contain minerals for
appropriately adjusting the hardness thereof.
The pre—extraction may be performed at any
extraction temperature and is usually performed at about 50°C
to 100°C, preferably about 60°C to 95°C, and more preferably
about 70°C to 90°C. The extraction time is about 1 min to 24
hours, preferably about 3 min to 20 hours. The extraction
conditions such as extraction temperature and time are
adjusted such that the removal rate of the soluble component
-14_
in the resulting tion residue is 60% or more, ably
70% or more, more preferably 80% or more, more preferably 90%
or more, and particularly preferably 95% or more. The l
rate of the soluble component means the relative proportion of
the solid collected with the extracting solution when the
maximum amount of the removable soluble component is defined
as 100%, and is the value calculated by the expression: "(the
amount (total amount: g) of solution obtained by pre—
extraction x its Brix [Bx])/(the maximum amount (g) of the
removable soluble component X its Brix [Bx]) x 100(%)".
Throughout the specification, "the maximum amount of the
removable soluble component" is conveniently denoted by "the
amount of the on obtained by repeating, ten times,
extraction with boiling water of an amount of 30 times the
weight of the plant for 10 min". Throughout the specification,
the term "Bx" can be measured with a commercially available Bx
scale.
The pre—extraction of a plant may be med once
or several times. The extract obtained by pre~extraction may
be discarded or may be used by being added to a food or drink.
For example, the extract mixed with a plant extract containing
a diketopiperazine prepared by the present invention can be
added to a food or drink.
(Heat treatment)
In the production method of the present invention,
diketopiperazines are generated by subjecting such plant
es to high—temperature and ressure treatment in a
liquid. The liquid for the high-temperature and high~pressure
_15._
treatment is preferably pure water and may be pure water
appropriately containing an organic solvent, such as ethanol.
The extracting solvent may contain minerals for riately
adjusting the hardness thereof. The liquid for the heat
treatment is optionally concentrated or diluted to have a Brix
(Bx) of about 0.1 to 50.
Throughout the specification, the term "high~
temperature and high~pressure" refers to a temperature of
100°C or more and a pressure exceeding the atmospheric
pressure. As a high—temperature and high—pressure extracting
apparatus, for e, a pressure—resistant extracting
apparatus, a pressure cooker, or an autoclave can be used
ing on the conditions.
The ature of the high—temperature and high—
pressure is preferably 100°C to 170°C, more preferably 110°C to
150°C, and particularly preferably 120°C to 140%L In the case
of using a pressure—resistant ting apparatus as the
g apparatus, this temperature is the measured outlet
temperature of the extraction column. In the case of using an
autoclave as the heating apparatus, this temperature is the
measured temperature at the center of the pressure vessel.
The pressure is preferably 0.101 to 0.79 MPa and more
preferably 0.101 to 0.48 MPa. The g time is preferably
about 30 to 500 minutes and more preferably about 60 to 300
minutes.
r optimum conditions for heat treatment are
within a range of time and temperature surrounded by the
following coordinate systems (i) to (vi), in which time (min)
-16—
is plotted on the horizontal axis and temperature (°C) on the
vertical axis.
(i) (170°C, 30 min), (ii) (150°C, 30 min), (iii)
(115°C, 180 min), (iv) (105°C, 480 min), (v) (135°C, 480 min),
and (vi) (150°C, 180 min).
After the high—temperature and high~pressure treatment in
a liquid, the liquid fraction is collected by optionally
performing solid—liquid separation to obtain a plant extract
ning a high concentration of the diketopiperazines of
the present invention. The solid—liquid separation is
achieved by filtration and/or centrifugation.
Although the composition of the diketopiperazines in
the resulting plant extract containing a high concentration of
the diketopiperazines varies depending on the origin (the type
of the plant as the raw material) of the plant peptides and
the type of the enzyme, the high—temperature and ressure
treatment of the plant peptides of the present invention in a
liquid can increase the amount of at least one
diketopiperazine selected from the group consisting of cyclo—
alanyl—glutamine (CAS Registry Number: 268221—76~7; Cyclo(Ala—
Gln)), histidyl—proline (CAS Registry Number: 53109—32~
3; His—Pro)), cyclo—alanyl—alanine (CAS Registry Number:
5845—61—4; Cyclo(Ala—Ala)), glycyl—proline (CAS ry
Number: 3705—27—9; Cyclo(Gly—Pro)), cyclo—seryl—tyrosine (CAS
Registry Number: 31—4; Cyclo(Ser—Tyr)), cyclo—prolyl—
threonine (CAS Registry Number: 227777—31—3; Cyclo(Pro—Thr)),
histidyl~phenylalanine (CAS Registry Number: 56586—95-9;
Cyclo(His—Phe)), cyclo—alanyl—proline (CAS ry Number:
-l7_
65556—33—4; Cyclo(Ala—Pro)), cyclo—phenylalanyl-serine (CAS
ry Number: 35591—00—5; Cyclo(Phe-Ser)), cyclo—glycyl-
leucine (CAS Registry Number: 7—0; Cyclo(Gly—Leu)),
cyclo—glycyl—phenylalanine (CA8 Registry Number: 10125—07—2;
Gly—Phe)), cyclo—propyl—proline (Cyclo(Pro-Pro)), cyclo-
glycyl—tryptophan (Cyclo(Gly-Trp)), cyclo—aspartyl—
phenylalanine (CAS Registry Number: 5262-10—2; Cyclo(Asp—Phe)),
valyl—proline (Val—Pro)), cyclo-prolyl—tyrosine
(Cyclo(Pro—Tyr)), methionyl—proline (Cyclo(Met—Pro)),
methionyl—methionine (Cyclo(Met—Met)), cyclo—valyl—
valine (Cyclo(Val-Val)), cyclo—leucyl—proline (CAS Registry
Number: 2873—36—1; Cyclo<Leu—Pro)), cyclo—tryptophanyl—
tyrosine (Cyclo(Trp-Tyr)), cyclo—phenylalanyl—proline (CAS
Registry Number: 3705—26—8; Cyclo(Phe-Pro)), cyclo—leucyl—
tryptophan (CA8 Registry Number: 15136—34—2; Cyclo(Leu—Trp)),
cyclo-phenylalanyl—tryptophan (CAS Registry Number: 82597—82v
8; Cyclo(Phe—Trp)), cyclo—leucyl-phenylalanine (CAS Registry
Number: 7280—77~5; Cyclo(Leu—Phe)), cyclo—leucyl—leucine (CA8
Registry Number: 952—45—4; Cyclo(Leu—Leu)), and cyclO*
phenylalanyl—phenylalanine (CAS Registry Number: 2862~51—3;
Cyclo(Phe~Phe)).
In particular, the present invention is advantageous
for production of a plant extract containing a high
concentration of diketopiperazines including Cyclo(Leu—Leu)
and Cyclo(Leu—Phe) in relatively high concentrations. The
t invention is also advantageous for production of a
plant t containing a high concentration of Cyclo(Phe—
Phe).
...18_.
A natural plant—derived diketopiperazine containing
a high concentration of a specific diketopiperazine can be
selectively produced from a plant extract containing a high
concentration of the diketopiperazine of the present invention
by known purification treatment. Accordingly, from one
viewpoint, the present invention relates to a method for
producing a plant t containing a high concentration of
diketopiperazines including Cyclo(Leu—Leu) and Phe-Phe),
and from another int, the present invention relates to a
method for producing a specific diketopiperazine (for example,
Cyclo(Ala—Ala), Cyclo(Leu—Phe), Cyclo(Leu—Leu), or Cyclo(Phe—
Phe)).
(Plant extract)
Throughout the specification, the term "extract" refers
to a liquid extract, and a "plant extract" of the present
invention refers to a liquid extract prepared by extraction
treatment of a plant or its processed product.
The t invention can provide a plant extract
containing at least one of Cyclo<Ala—Gln), Ala—Ala),
Ser—Tyr), Gly—Trp), Cyclo(Val~Val), Cyclo(Trp—Tyr),
Cyclo(Leu—Trp), and Cyclo(Phe*Phe) in an amount per Bx of
pg/lOO g/Bx or more.
In addition, the present invention can provide a
plant extract containing diketopiperazines in a total amount
of 900 pg/lOO g or more, preferably 1000 pg/lOO g or more,
more preferably 2000 ug/lOO g or more, and particularly
preferably 5000 ug/lOO g or more. Throughout the
specification, unless otherwise specified, the total amount of
_19_
diketopiperazines refers to the sum of the amounts of Cyclo
(Ala—Gin), Cyclo (His—Pro), Cyclo (Ala—Ala), Cyclo (Gly—Pro),
Cyclo (Ser—Tyr), Cyclo (Pro—Thr), Cyclo (His—Phe), Cyclo (Ala-
Pro), Cyclo (Phe—Ser), Cyclo (Gly—Leu), Cyclo (Gly—Phe), Cyclo
(Pro—Pro), Cyclo (Gly-Trp), Cyclo (Asp—Phe), Cyclo (Val—Pro),
Cyclo (Pro-Tyr), Cyclo (Met—Pro), Cyclo (Met~Met), Cyclo (Val—
Val), Cyclo (Leu—Pro), Cyclo (Trp~Tyr), Cyclo ro), Cyclo
(Leu—Trp), Cyclo (Phe—Trp), Cyclo (Leu—Phe), Cyclo (LeU*Leu),
and Cyclo (Phe—Phe).
In general, since an extract having a high Bx
contains s substances (e.g., bitter substances) d
from the raw material at a high concentration, the extract
itself is improper as a drink, and addition of the extract to
a drink is also er due to influence on the flavor or the
feeling on the tongue. Accordingly, regarding the addition to
drink, a lower Bx is preferred. The present invention can
provide a plant extract containing a large amount of
diketopiperazines of physiologically active substances and
having a low Bx, i.e., a plant t having a high ratio of
the content of diketopiperazines to the Ex. Specifically,
provided is a plant extract having a ratio of the total amount
(unit: ug/lOO g) of the above—mentioned diketopiperazines to
Brix (Bx) of 900 (pg/100 g/Bx) or more, preferably 1000
(ug/lOO g/Bx) or more, more ably 2000 (pg/100 g/Bx), and
further preferably 5000 (pg/100 g/Bx). The upper limit of the
amount of diketopiperazines in an extract is not particularly
limited and may be appropriately ined in the light of
the solubility of the diketopiperazines and is usually about
_20__
1000 mg/100 g or less, preferably about 500 mg/100 g or less,
and more preferably about 200 mg/100 g or less.
In the case of a plant extract prepared by applying
the tion method of the present invention to a plant as a
raw material, the generation of by—products is low, because no
fermentation is performed. In addition, the pre—extraction
reduces the amount of the soluble component to give a plant
extract having a characteristic flavor of icantly low
bitterness.
Such a plant t has a good flavor and also an
excellent appearance without, for example, precipitation and
turbidity and can be ore used directly as an t or
for seasonings, drinks, and other foodstuffs without
performing specific pro—treatment. The plant extract of the
present invention contains a large content of
diketopiperazines, but has a relative low Bx. Accordingly,
the amount to be added to a food or drink (in particular,
drink) may be low, which is an advantage of increasing the
degree of freedom in design of a food or drink. In particular,
the plant tion can be ly mixed with a drink mainly
composed of an extract or juice of a plant, such as a tea
drink, a coffee drink, a soybean drink, or a fruit juice drink
or a soft drink, such as flavored water, mineral water, or a
carbonated drink. For example, a drink mixed with a plant
extract of the present invention such that the total amount of
diketopiperazines is 10 ug/lOO g or more, preferably
ug/lOO g or more, more preferably 40 ug/lOO g or more, and
further preferably 60 ug/lOO g or more can have good taste
without having bitterness.
The plant extract prepared by the t invention
may be ted to, for example, clarification treatment
depending on the form of the food or drink to which the plant
extract is added. In such a case, the plant extract has an
advantage that the ication can be easily performed,
e, for example, that the extract does not n oil
and includes fibers.
Examples of preferred form of the plant extract of
the present invention include tea extracts, soybean extracts,
and malt ts. These extracts will now be described in
detail.
(Tea extract)
Throughout the specification, the term "tea extract"
refers to a tea extract prepared by extraction treatment of
tea leaves. The tea leaves of the extraction raw material are
drinkable parts by extraction of a tea plant (scientific name:
Camellia is), such as leaves and stems of tea leaves.
In addition, the tea leaves may be in any form, such as a
macrophyll or powder form“ The harvest time of tea leaves may
be any time and is appropriately selected to obtain a desired
flavor.
The plant extract (tea extract) containing a high
concentration of diketopiperazines prepared by the present
invention is characterized by the production process without
performing fermentation to inhibit the generation of by-
products and to obtain good flavor. From the viewpoint of
this flavor, the tea leaves are preferably of steamed
-22_
ented tea (green tea), such as sencha, bancha, houjicha,
gyokuro, kabusecha, and sweet tea, or unfermented kamairi tea,
such as ureshinocha, aoyagicha, or a variety of Chinese tea.
The present inventors measured the concentrations of
diketopiperazines in tea extracts prepared by extracting
cially available tea leaves. The results demonstrate
that fermented tea contains a significantly low amount (about
0 to 200 ug/lOO g/Bx) of the diketopiperazines and that green
tea does not substantially contain the diketopiperazines (see
Table 1, the ement method is the same as that shown in
Example 1).
_23_
[Table 1]
Dl- k -
etOplperaZlne'
Green Pu—erh Pu-erh
concentration GOishicha
(min) tea tea 1 tea 2
(ppm/Bx)
U) Ala—Gin Q
torotoooooooooqqowowo'lmma-w mfiNkOONONI—‘OOQQU‘IOOOOOWQN His—Pro
Ala—Ala
Ser-Tyr
Pro—Thr
His—Phe .1.0000000
Ala—Pro
Gly—Leu
Gly—Phe
Pro-Pro
Gly—Trp
Asp—Phe
Val—Pro
Pro—Tyr
Met—Pro
ll 1—4 O‘xthJOONOU'INJNN Phe—Pro
Leu—Trp
Phe—Trp
Leu—Phe
Leu—Leu/Ile—Ile
Phe—Phe OOOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOQOOOOOOOO OOOOOHONOOOHl—JOOHOOONOQOHONO OOOOOOOOOOOOOOOOOOOO OOOOOI—‘OHOOOI—‘NOOI—‘OOOWONOI—‘OOO OOOOOOOOOOOOOOOOOOOQ OOOOOI—‘Of—‘OOOHNOOF—‘OOONOl—‘Ol—‘OOO
Total
concentration 0.0 1.9 1.2 0.8
(ppm/BX)
Total
concentration per
O 193 119 82
unit BX
(ug/lOOg/Bx)
In contrast, the tea extract of the present
ion contains at least one of Cyclo<A1a—Gln), Cyclo(Ala—
Ala), Ser—Tyr), Cyclo(G1y—Trp), Cyclo(Val—Val),
_24_.
Cyclo(Trp—Tyr), Cyclo(Leu—Trp), and Cyclo(Phe-Phe) of
diketopiperazines, which are not contained in conventional
teas, at a concentration of 10 ug/lOO g/Bx or more.
Alternatively, the tea extract of the present
invention contains each of Cyclo (Ala—Gln), Cyclo (His-Pro),
Cyclo la), Cyclo (Gly—Pro), Cyclo yr), Cyclo (Pro—
Thr), Cyclo (His—Phe), Cyclo (Ala—Pro), Cyclo (Phe~Ser), Cyclo
(Gly—Leu), Cyclo (Gly—Phe), Cyclo (Pro—Pro), Cyclo (Asp—Phe),
Cyclo ro), Cyclo (Pro—Tyr), Cyclo (Met—Pro), Cyclo (Leu—
Pro), Cyclo (Phe—Pro), Cyclo (Leu—Phe), and Cyclo (Leu-Leu) at
a concentration of 0.1 ppm/Bx (10 ug/lOO g/Bx) or more. The
tea extract preferably contains each of the above—mentioned
piperazines at a concentration of 0.2 ppm/Bx or more,
more preferably 0.3 ppm/Bx or more, further preferably
0.4 ppm/Bx or more, and particularly preferably 0.5 ppm/Bx or
more. Furthermore, the tea extract can contain each of
Cyclo(Gly—Trp), Cyclo<Val—Val), Cyclo(Trp—Tyr), Cyclo(Leu—Trp),
Cyclo(Phe—Trp), and Cyclo(Phe—Phe) at a concentration of
0.1 ppm/Bx (10 ug/lOO g/Bx) or more, preferably 0.2 ppm/Bx or
more, and more preferably 0.3 ppm/Bx or more.
piperazines known to have strong bitterness
are Cyclo(Leu—Pro) and Phe—Pro) of the diketopiperazines
contained in coffee drinks (see Japanese Patent Laid—Open
No. 2010—166911) and Cyclo(Leu—Trp) of a decomposition
treatment product of casein in Research Foundation,
Peptide Institute, Inc., No. 2, 1974). The tea extract of the
present invention contains these diketopiperazines having
strong bitterness, but the extract itself does not
substantially have bitterness. An aqueous solution containing
Leu—Pro), Cyclo(Phe—Pro), and Cyclo(Leu—Trp) at the same
concentrations as those of the tea t have strong
bitterness. It is therefore suggested that other
diketopiperazines and tea—derived component present in the tea
extract additively or synergistically reduce the bitterness of
Cyclo(Leu—Pro), Phe—Pro), and Cyclo(Leu-Trp). In
ular, a tea extract having a ratio [(B)/(A)] of the
total amount (B) of the diketopiperazines having bitterness,
Cyclo(Leu~Pro), Cyclo(Phe~Pro), and Cyclo(Leu—Trp), to the
total amount (A) of Cyclo(Leu—Leu) and Cyclo(Leu—Phe) of 1.0
or less (preferably 0.8 or less, more preferably 0.6 or less,
and particularly preferably 0.4 or less) is a
diketopiperazine—containing extract not having any taste such
as bitterness and can be directly added to foods and drinks
(in particular, drinks).
The total amount of the diketopiperazines per Bx in
the tea extract is 900 ug/lOO g/Bx or more, preferably 900 to
30000 ug/lOO g/Bx, more ably 2000 to 25000 ug/lOO g/Bx,
and particularly preferably 5000 to 20000 ug/lOO g/Bx. Such a
concentration range is advantageous for ing a food or
drink provided with the functions (such as physiological
activity) of the diketopiperazines.
Such a tea extract can be conveniently produced by
decomposing protein in tea leaves to prepare tea peptides and
subjecting the tea es to high—temperature and high—
pressure treatment. Tea leaves abundantly contain protein at
about 25% (Food Composition Table, 5th ed.). Accordingly, it
_26_
can be expected to obtain tea peptides by decomposition
treatment of the protein of tea leaves with an enzyme such as
a protease, but the action of proteases on tea leaves cannot
give a large amount of tea es. Since 80% or more of the
whole protein in tea leaves are insoluble n, it is
preferable to prepare tea peptides by efficiently acting a
proteolytic enzyme on the protein contained in tea leaves.
Specifically, water—soluble protein is removed from tea leaves
by eatment, and a proteolytic enzyme, such as a protease,
is allowed to act on the resulting extraction residue to
prepare tea peptides. That is, the tea extract of the present
invention containing a high concentration of diketopiperazines
can be conveniently produced by efficiently osing water~
insoluble protein by sequentially performing the following
steps:
(a) extracting tea leaves with water and collecting the
extraction residue;
(b) acting an endo—type se on the extraction
e in the presence of water to decompose the tea leaf
protein to prepare a solution containing tea peptides;
(c) subjecting the on containing tea peptides to
high—temperature and high~pressure treatment to prepare a
reaction solution; and
(d) subjecting the reaction solution to solid—liquid
separation treatment to collect a solution containing
diketopiperazines, or
(a) extracting tea leaves with water and collecting the
extraction residue;
-27_
(b) acting an endo—type protease on the extraction
residue in the presence of water to decompose the tea leaf
protein to prepare a on containing tea peptides;
(d') subjecting the solution containing tea peptides to
solid—liquid separation treatment to collect a solution
containing tea peptides; and
(C‘) subjecting the solution containing tea peptides to
emperature and high—pressure treatment to prepare a
on solution containing diketopiperazines.
The conditions for each step are as described above. In
the pre—extraction in the step (a), an extraction residue,
such as used tea leaves obtained by extraction ent in,
for example, production of tea drinks, can also be used.
Conventionally, the water—insoluble tea protein in tea leaves
has not been used as a nutrient source. For example, most of
more than 22000 tons of extraction residue generated in
production of green tea drinks in Japan have been discarded as
unused ces, but the above—described method for producing
a tea t is also useful for ive utilization of such
used tea leaves that have been conventionally discarded.
This method can produce tea extract containing a
high concentration of Cyclo(Leu-Leu), Cyclo(Leu—Phe), and
Cyclo(Ala—Ala). Specifically, the extract contains 10%
(weight basis) or more of Cyclo(Leu—Leu), 10% or more of
Leu—Phe), and 7% or more of Cyclo(Ala—Ala), based on the
total amount of the diketopiperazines in the tea extract.
When these weight basis contents are expressed by amounts, the
tea extract contains each of these diketopiperazines at a
concentration of 5.0 ppm/Bx (500 ug/lOO g/Bx) or more,
ably 8.0 ppm/Bx or more, and more preferably 10.0 ppm/Bx
or more. The upper limit thereof is about 50.0 ppm/Bx or less,
preferably about 40.0 ppm/Bx or less, more preferably about
.0 ppm/Bx or less, and further ably about 30.0 ppm/Bx
or less.
In addition, it was found that the trations of
Cyclo(Leu-Leu), Cyclo<Leu—Phe), and Cyclo(Phe—Phe) are notably
increased by repeating the water extraction (pre—extraction)
of tea leaves in the step (a) more than once. Accordingly,
this method is also advantageous for production of Cyclo(Phe—
Phe). The present inventors confirmed that a tea extract
containing 3.0 ppm/Bx or more of Phe-Phe) prepared by
this method has a learning motivation-improving action.
Incidentally, a diketopiperazine having a
hydrophobic functional group is known to enhance the
hydrophobicity, by being circularized, to a level higher than
that of the linear peptide. The results of an accelerated
preservation test (55°C, 2 weeks) of the above—described tea
extract demonstrate that Cyclo(Phe—Phe), which is a component
having the highest hydrophobicity, is stably retained.
ingly, the tea extract of the present ion is also
useful as a Cyclo(Phe-Phe)—containing extract. The content of
Cyclo(Phe—Phe) in the tea extract is preferably adjusted to
ug/lOO g/Bx or more, 20 ug/lOO g/Bx or more, or
ug/lOO g/BX or more.
(Soybean extract)
Throughout the specification, the term "soybean extract"
-29_
refers to a solution prepared by adding water to soybean and
performing extraction treatment or milling treatment. The
soybean (scientific name: Glycine max) as the raw material may
be any species and may be produced in any area. Soybean in a
stage of sing, such as crushed soybean, can also be used.
The soybean extract in this specification encompasses a
solution prepared by adding water to a soybean protein
decomposition product, as a matter of convenience.
It is said that n account for about 30% of
soybean. Since the n protein does not include a large
amount of water~insoluble protein, unlike the tea protein, the
pre-treatment for removing water—soluble protein is not
essential and may be optionally med. When the pre—
treatment for removing water~soluble protein is not performed,
a plant extract (soybean extract) containing a high
tration of diketopiperazines can be more conveniently
produced by a one~pot reaction.
The present inventors measured the concentrations of
piperazines in n peptides in View of that
commercially available soybean peptides (powder) have been
applied with heat about 180°C to 220°C during spray drying.
The results demonstrate that a significantly low amount (about
650 ug/lOO g/Bx) of diketopiperazines are present in the
commercially available soybean peptides (see Table 2).
In contrast, the soybean extract of the present
ion contains at least one of Cyclo(Ala—Gln), Cyclo(Ala—
Ala), Cyclo(Ser—Tyr), Cyclo(Gly—Trp), Cyclo(Val—Val),
Cyclo(Trp—Tyr), Cyclo(Leu—Trp), and Cyclo(Phe—Phe) of
~30...
diketopiperazines, which are not contained in conventional
soybean protein decomposition products (soybean peptides), in
an amount per Bx of 10 ug/lOO g/Bx or more.
In addition, the soybean extract of the present
invention contains each of Cyclo (Ala—Gln), Cyclo (His—Pro),
Cyclo (Ala—Ala), Cyclo ro), Cyclo (Ser-Tyr), Cyclo (Pro—
Thr), Cyclo he), Cyclo (Ala-Pro), Cyclo (Phe—Ser), Cyclo
(Gly—Leu), Cyclo (Gly—Phe), Cyclo (Gly-Trp), Cyclo (Asp-Phe),
Cyclo (Val-Pro), Cyclo (Pro—Tyr), Cyclo (Met~Pro), Cyclo (Val—
Val), Cyclo (Leu—Pro), Cyclo (Trp—Tyr), Cyclo (Phe—Pro), Cyclo
(Leu—Trp), Cyclo (Leu—Phe), Cyclo (Leu—Leu) and Cyclo (Phe—
Phe) at a concentration of 0.1 ppm/Bx (lO ug/lOO g/Bx) or more.
The soybean extract preferably contains each of the above—
ned diketopiperazines at a concentration of 0.5 ppm/Bx
or more, more preferably 0.7 ppm/Bx or more, further
preferably 0.9 ppm/Bx or more, ularly preferably
1.0 ppm/Bx or more, and particularly preferably 1.2 ppm/Bx or
more. rmore, the soybean extract can contain each of
Cyclo(Pro—Pro) and Cyclo(Phe—Trp) at a concentration of
0.1 ppm/Bx (10 ug/lOO g/Bx) or more, preferably 0.2 ppm/Bx or
more, and more preferably 0.3 ppm/Bx or more.
This soybean extract (in ular, an extract
prepared using soybean or its ground product as a raw
al) contains Cyclo(Leu—Pro), Cyclo(Phe—Pro), and
Cyclo(Leu—Trp), which are known as diketopiperazines having
strong bitterness, but the t has reduced bitterness. An
aqueous solution containing Cyclo(Leu—Pro) and Cyclo(Phe—Pro)
at the same concentrations as those of the soybean extract
_31_
have strong bitterness. It is therefore suggested that other
diketopiperazines and soybean—derived component present in the
soybean extract additively or synergistically reduce the
ness of Cyclo(Leu—Pro), Cyclo(Phe—Pro), and Cyclo(Leu—
Trp). In particular, a soybean t having a ratio
[(B)/(A)] of the total amount (B) of the piperazines
having bitterness, Cyclo(Leu—Pro), Cyclo(Phe—Pro), and
Cyclo(Leu—Trp), to the total amount (A) of Cyclo(Leu—Leu) and
Cyclo(Leu-Phe) of 1.0 or less (preferably 0.8 or less, more
preferably 0.6 or less, and particularly preferably 0.5 or
less) is a diketopiperazineecontaining extract having
significantly reduced bitterness and can be advantageously
mixed with foods and drinks (in ular, drinks).
The total amount of the diketopiperazines per Bx in
the soybean extract is 900 ug/lOO g/Bx or more, preferably 900
to 30000 ug/lOO g/Bx, more preferably 2000 to
25000 ug/lOO g/Bx, and particularly preferably 5000 to
20000 ug/lOO g/Bx. Such a concentration range is advantageous
for producing a food or drink provided with the functions
(such as physiological activity) of the diketopiperazines.
The soybean extract of the present invention
containing a high concentration of diketopiperazines can be
produced by sequentially performing the ing steps:
(x) acting an endo—type protease on soybean or a soybean
protein decomposition t in the presence of water to
prepare a solution containing n peptides;
(y) subjecting the solution ning soybean peptides
to highetemperature and high—pressure treatment to prepare a
-32_
on solution; and
(z) subjecting the reaction solution to solid—liquid
separation treatment to collect a solution containing
diketopiperazines.
As in production of the tea extract, the order of the
steps (y) and (2) may be exchanged. In addition, before the
step (x), a step (w) of removing water~soluble protein may be
performed. In the case of using soybean peptides including a
large amount of di— or tripeptides as a raw al, the step
(x) is performed by:
(x') adding water to soybean peptides including a large
amount of di- or tripeptides to prepare a solution containing
the soybean peptides.
The conditions of other steps are the same as those
described above.
This method can produce a soybean extract containing
a high concentration of Cyclo(Leu—Leu), Cyclo(Leu—Phe),
Cyclo(Ser*Tyr), and Cyclo (Pro—Thr). ically, the
extract contains 8% (weight basis) or more of Cyclo(Leu-Leu),
8% or more of Cyclo(Leu—Phe), and 6% or more of Cyclo(Ser—Tyr),
based on the total amount of the diketopiperazines in the
soybean extract. The n extract contains each of these
piperazines at a concentration of 5.0 ppm/Bx
(500 pg/lOO g/Bx) or more, preferably 6.0 ppm/Bx or more, and
more preferably 7.0 ppm/Bx or more. In particular, a soybean
extract containing each of Leu—Leu) and Cyclo(Leu—Phe)
at 10.0 ppm/Bx or more, preferably 12.0 ppm/Bx or more, can be
prepared. The upper limit thereof is about 50.0 ppm/Bx or
_33...
less, preferably about 40.0 ppm/Bx or less, more preferably
about 35.0 ppm/Bx or less, and further preferably about
.0 ppm/Bx or less.
In addition, this method can provide a soybean
extract containing 3.0 ppm/Bx or more, preferably 4.0 ppm/Bx
or more, of Cyclo(Phe-Phe), which is not included in soybean
peptides, and is therefore also advantageous for producing
Cyclo(Phe-Phe) (see Examples described below). Incidentally,
it has been confirmed that Cyclo(Phe—Phe), which is a highly
hydrophobic component, is stably retained in this soybean
extract.
(Malt extract)
Throughout the specification, the term "malt extract"
refers to an extract prepared by extraction ent of malt
or its ground product. The soybean malt (malt) as the raw
material may be any species and may be ed in any area.
In particular, barley malt, which is germinated seeds of
barley, is preferably used. It is practical and efficient to
use a fraction containing a large amount of protein ted
from barley malt by ng the skin. The fraction
containing a large amount of protein can be obtained by, for
example, gradually scraping the surface of malt to remove the
husk and then collecting a fraction containing a large amount
of protein, such as the aleurone layer and endosperm, by
scraping. Alternatively, as performed for the tea extract, an
extraction residue after pre—extraction can be used. es
of the extraction e include the malt pomace ted in
the production of beer.
-34_
A plant extract (malt extract) containing a high
tration of diketopiperazines can be more conveniently
produced by a one—pot reaction by using a on containing
a large amount of protein as a raw material.
The malt extract of the present invention contains
at least one of Cyclo(Ala—Gln), Cyclo(Ala—Ala), Cyclo(Ser—Tyr),
Cyclo(Gly—Trp), Cyclo<Val—Val), Cyclo(Trp—Tyr), Cyclo(Leu-Trp),
and Phe~Phe), which are diketopiperazines that have been
conventionally hard to be extracted, at a concentration of
ug/lOO g/BX or more.
In addition, the malt extract of the present
invention contains each of Cyclo (Ala—Gln), Cyclo (His—Pro),
Cyclo (Ala—Ala), Cyclo (Gly—Pro), Cyclo (Ser—Tyr), Cyclo (Pro—
Thr), Cyclo (His—Phe), Cyclo ro), Cyclo (Phe-Ser), Cyclo
(Gly—Leu), Cyclo (Gly—Phe), Cyclo rp), Cyclo (Asp—Phe),
Cyclo (Val—Pro), Cyclo (Pro—Tyr), Cyclo (Met—Pro), Cyclo (Val—
Val), Cyclo (Leu—Pro), Cyclo (Trp—Tyr), Cyclo (Phe—Pro), Cyclo
(Leu~Trp), Cyclo (Leu-Phe), Cyclo (Leu—Leu) and Cyclo (Phe—
Phe) at a concentration of 0.1 ppm/Bx (50 Hg/lOO g/Bx) or more.
The malt extract preferably contains each of the above—
mentioned diketopiperazines at a concentration of 0.3 ppm/Bx
or more, more preferably 0.4 ppm/Bx or more, further
preferably 0.5 ppm/Bx or more, and particularly preferably
0.6 ppm/Bx or more.
This malt extract contains Cyclo(Leu—Pro),
Cyclo(Phe—Pro), and Leu—Trp), which are known as
diketopiperazines having strong bitterness, but the extract
has reduced bitterness. In particular, a malt extract having
-35_
a ratio [(B)/(A)] of the total amount (B) of the
diketopiperazines having bitterness, Cyclo(Leu—Pro),
Cyclo(Phe—Pro), and Cyclo(Leu—Trp), to the total amount (A) of
Leu—Leu) and Cyclo(Leu—Phe) of 1.0 or less (preferably
0.8 or less) is a diketopiperazine~containing extract having
significantly reduced bitterness and can be advantageously
mixed with foods and drinks (in particular, drinks).
The total amount of the diketopiperazines per Bx in
the malt extract is 900 ug/lOO g/Bx or more, preferably 900 to
30000 ug/lOO g/Bx, more ably 2000 to 25000 pg/lOO g/Bx,
and particularly preferably 5000 to 20000 ug/lOO g/Bx. Such a
concentration range is advantageous for producing a food or
drink provided with the functions (such as physiological
activity) of the diketopiperazines.
The malt extract of the present ion containing
a high concentration of diketopiperazines can be produced by
sequentially performing the following steps:
(x) acting an endo—type protease on malt or a malt
protein decomposition product in the presence of water to
prepare a solution ning malt peptides;
(y) subjecting the solution ning malt peptides to
high—temperature and high—pressure treatment to prepare a
on solution; and
(z) subjecting the reaction solution to solid—liquid
separation treatment to collect a solution containing
diketopiperazines.
As in production of the tea extract, the order of the
steps (y) and (2) may be exchanged. In addition, before the
-36_
step (x), a step (w) of removing water—soluble protein may be
performed. The conditions of other steps are the same as
those described above.
This method can produce a malt extract containing a
high concentration of Cyclo(Leu—Leu), Cyclo(Leu—Phe), and
Cyclo(Ala—Ala). Specifically, the malt extract ns each
of these diketopiperazines at a concentration of 5.0 ppm/Bx
(500 ug/lOO g/Bx) or more, preferably 6.0 ppm/Bx or more, and
more preferably 7.0 ppm/Bx or more. The upper limit thereof
is about 50.0 ppm/Bx or less, preferably about 40.0 ppm/Bx or
less, more preferably about 30.0 ppm/Bx or less, and further
preferably about 20.0 ppm/Bx or less.
In on, this method can provide a malt extract
containing 1.0 ppm/Bx or more, preferably 2.0 ppm/Bx or more,
and further preferably 3.0 ppm/Bx or more of Phe—Phe)
and is therefore also advantageous for ing Cyclo(Phe—
Phe).
EXAMPLES
The present invention will now be described based on
Examples, but is not limited to the following Examples.
Throughout the specification, unless otherwise specified, the
concentrations are weight basis, and the numerical value
ranges each include their endpoints.
(Example 1) Production of diketopiperazine from
plant peptide
Soybean peptides and sesame peptides were used as plant
peptides and were ted to emperature and high—
pressure treatment in liquids to produce plant extracts
137_
containing high concentrations of diketopiperazines.
Specifically, 15 mL of distilled water was added to 3 g of
soybean peptides (HINUTE AM, manufactured by Fuji Oil Co.,
Ltd.) or sesame peptides (KM—20, manufactured by KISCO Ltd.),
and the mixture was put in an autoclave (manufactured by Tomy
Seiko Co., Ltd.) and was subjected to high~temperature and
ressure treatment at 135°C and 0.31 MPa for 3 hours. In
addition, as a Comparative Example, the same peptides were
used to prepare an t without being subjected to the
high—temperature and ressure treatment. After the
treatment, 10 mL of each solution was diluted 50—fold,
subjected to membrane treatment, and then applied to LC—MS/MS
to determine the concentration of each diketopiperazine. The
details of the analysis conditions were as shown below. In
addition, the Brix (Bx) of each plant extract ning a
high concentration of diketopiperazines was measured with a
digital tometer RX—SOOOa (manufactured by ATAGO Co.,
Ltd.), and the ratio of the total amount (unit: ug/lOO g) of
diketopiperazines to Brix (Bx) was calculated.
[Formula 1]
(LC—MS/MS analysis conditions)
LC tus: SHIMADZU UFLC XR
Column: Agilent technologies Zorbax SB—AQ 1.8 um 2.1 x
150 mm
Column temperature: 40°C
Mobile phase: A: 0.1% formic acid, B: methanol nt
analysis
Flow rate: feed ratio 0: 0.2 mL/min
_38_
Injection amount: 2 uL
Detector: AB Sciex 4000 Q TRAP (R) — Turbo Spray (ESI) —
Scheduled multiple reaction ring (MRM)
Nozzle position: top: 4 mm, side: 7 mm
MRM detection window: 40 sec, Target Scan Time: 0.5 sec
[Positive mode] analysis at Scheduled MRM
Ion source condition: CUR 20.0, CAD 6, IS 5500, TEM 700,
G81 70, G82 70
Table 2 shows the results (throughout the
specification, Cyclo(Leu—Leu) denotes the sum of Cyclo(Leu—
Leu) and Cyclo(Ile—Ile)). It was demonstrated that plant
ts containing a high concentration of diketopiperazines
can be conveniently produced by the high—temperature and high—
pressure treatment in a liquid according to the present
invention. In addition, it was suggested that it is possible
to increase the amount of at least one diketopiperazine
selected from the group consisting of Cyclo (Ala-Gln), Cyclo
(His-Pro), Cyclo la), Cyclo (Gly—Pro), Cyclo yr),
Cyclo hr), Cyclo (His-Phe), Cyclo (Ala~Pro), Cyclo (Phe—
Ser), Cyclo (Gly—Leu), Cyclo (Gly—Phe), Cyclo (Pro—Pro), Cyclo
rp), Cyclo (Asp—Phe), Cyclo (Val—Pro), Cyclo (Pro—Tyr),
Cyclo (Met-Pro), Cyclo (Met~Met), Cyclo (Val-Val), Cyclo (Leu—
Pro), Cyclo (Trp—Tyr), Cyclo (Phe—Pro), Cyclo (Leu~Trp), Cyclo
(Phe—Trp), Cyclo (Leu-Phe), Cyclo (Leu~Leu), and Cyclo (Phe—
Phe). In particular, Cyclo(Leu—Leu) and Leu-Phe) were
contained at high concentrations. The content of these
diketopiperazines was 21.5% in the plant extract containing
them at a high concentration.
_39_
[Table 2]
RT piperaZine The present Comparative The present
concentration
(min) invention 1 t invention 2
(ppm/Bx)
Cyclo(Ala—Gln) 6.8 0.0 3.0
3.7 Cyclo(His—Pro 6.7 0.9 1.8
4.4 Cyclo(Ala—Ala) 6.1 0.0 2.8
.6 Cyclo(Gly~Pro 5.3 0.0 0.3
.8 Cyclo(Ser~Tyr 11.7 0.0 1.3
.8 Cyclo(Pro—Thr 8.1 0.5 2.6
6.5 Cyclo(His—Phe 6.1 0.1 3.3
6.7 Cyclo(Ala~Pro 6.9 0.8 2.1
7.4 Cyclo(Phe—Ser) 4.3 0.1 1.3
7.8 Cyclo(Gly—Leu 4.5 0.0 4.4
t:§:68.1 Cyclo(Gly—Phe) 6.1 0.1 6.7
Cyclo(Pro—Pro 0.4 0.0 0.1
8.6 Cyclo(Gly—Trp) 1.5 0.0 0.0
8.9 6.8
9-2 0.4
9.4 0.3
9.6 Cyclo(Met—Pro) 2.7 0.5 0.1
.2 Cyclo(Met—Met)t 0.2 0.1 2.0
.2 Cyclo(Val—Val) 1.7 0.0 0.4
.7 Leu—Pro) 6.9 1.1 1.5
.5 Cyclo(Trp-Tyr) 1.0 0.0 0.3
L_11.0 Cyclo(Phe—Pro) 8.1 0.4 0.0
11.2 Cyclo(Leu—Trp) 2.7 0.0 4.2
11.8 Cyclo(Phe—Trp) 0.3 0.1 3.9
_~_'
1 .3 Cyclo(Leu—Phe) 14.5 0.3 l 5.5
12.4 Cyclo(Leu—Leu) 17.9 0.4 6.8
_4___
12.6 Cyclo(Phe—Phe) 4.3 0.0 2.8
tration 150.7 6.5 64.6
(ppm/BX) '
Total
concentration per
15067 652 6460
unit Bx
(ug/lOOg/Bx)
(Example 2) Production of Cyclo<Phe—Phe) from plant
peptide
_40_
The plant peptides used were as follows:
1) soybean peptides "HINUTE AM" (manufactured by Fuji Oil
Co., Ltd.): di and tripeptides: 67%, average molecular weight:
2) soybean peptides "HINUTE DC" (manufactured by Fuji Oil
Co., Ltd.): chain length: 3 to 7, average molecular weight:
1000
3) soybean peptides "HINUTE HK" (manufactured by Fuji Oil
Co., Ltd.)
4) rice es "Oryza Peptide" actured by Oryza
Oil & Fat Chemical Co., Ltd.): tripeptides: 40% to 50%
) wheat peptides "Glutamine e GP—lN" (manufactured
by Nisshin Pharma Inc.): molecular weight: 5000 to 10000
6) wheat peptides "Glutamine Peptide GP—N" (manufactured
by Nisshin Pharma Inc.): molecular : 5000 to 10000
To 3 g of the peptides of each plant was added 15 mL of
distilled water, and the e was put in an autoclave
(manufactured by Tomy Seiko Co., Ltd.) and was subjected to
high-temperature and high-pressure treatment at 132°C and
0.29 MPa for 2 hours. After the ent, 10 mL of each
solution was subjected to solid—phase extraction with OASIS
MAX (manufactured by Waters Corporation). The resulting
solid—phase extract was concentrated under reduced pressure
and was then dissolved in 100 uL of DMSO. Using 10 uL of the
solution, the concentration of cyclo—phenylalanyl—
phenylalanine was determined by high—performance liquid
tography (HPLC).
Table 3 shows the results. The degree of generation
-41...
of cyclo—phenylalanyl—phenylalanine varied depending on the
type of the peptides. Soybean peptides generated a high
concentration of cyclo—phenylalanyl—phenylalanine compared to
the cases of using rice peptides and wheat peptides. This
suggested that it is preferable to use soybean peptides
including peptides having a molecular weight of 5000 or less
(in particular, a molecular weight of 1000 or less) at a high
proportion. Comparison of different soybean peptides
suggested that it is preferable to use oligopeptides having a
lower molecular weight and containing a large amount of di-
and tripeptides as a raw material.
[Table 3]
Soybean peptide
Diketopiperazine
HINUTE HINUTE HINUTE
concentration Peptide
AM DC HK
(Hg/ml) GP-N
Phe—Phe 38.4 25.8 15.1_4 3.2 ‘ 0.59 0.33
Bx 20.66 20.10 19.42
Total
concentration 186 128 78
per unit Bx
L(Mg/100g/Bx)
(Example 3) Production of diketopiperazine from
plant—derived protein
A plant~derived protein subjected to osition
treatment with an enzyme was used as the raw al. The
plant—derived protein used was soybean protein na 900
(manufactured by Fuji Oil Co., Ltd.)) and rice protein (Oryza
Protin P70 (manufactured by Oryza Oil & Fat Chemical Co.,
Ltd.)), and 300 mg of each n was added to 15 mL of
led water. To each mixture, was added 15 mg of any of
_42_
enzyme A (ProteAX), enzyme B (Newlase F3G: acid protease
(endopeptidase) derived from us niveus), enzyme C
(Papain W—40: se derived from Carica papaya), enzyme D
(protease A "Amano" SD: protease derived from Aspergillus sp.),
enzyme E (protease M "Amano" SD: protease derived from
Aspergillus sp.), enzyme F (protease P "Amano" 3SD: derived
from illus sp.), enzyme G (Promelain F: protease from
Ananas comosus), enzyme H (Peptidase R), enzyme I (Thermoase
PClOF: protease (endopeptidase) derived from Bacillus
stearothermophilus), enzyme J (Protin SD—NYlO: protease
derived from Bacillus sp.), and enzyme K (Protin SD—AYlO:
protease derived from Bacillus sp.) (all manufactured by Amano
Enzyme Inc.), and the resulting mixture was shaken and mixed
at 37°C for 2 hours. This enzyme—treated solution was then
subjected to heat ent t ming solid—liquid
separation. The heat treatment was high—temperature and high—
pressure treatment at 132°C for 2 hours in an ave
(manufactured by Tomy Seiko Co., Ltd.). In addition, the
soybean protein and the rice protein not treated with any
enzyme were rly treated. After the treatment, 10 mL of
each solution was subjected to solid-phase extraction with
OASIS MAX (manufactured by Waters Corporation). The resulting
solid—phase extract was concentrated under reduced pressure
and was then dissolved in 100 uL of DMSO. Using 10 uL of the
solution, the tration of cyclo—phenylalanyl—
phenylalanine was determined by high-performance liquid
chromatography (HPLC).
Fig. 1 shows the results in the case of using the
-43—
soybean protein, and Fig. 2 shows the results in the case of
using the rice protein. Protein not subjected to
osition ent with an enzyme (Untreated) also
generated the diketopiperazine by heat treatment. It was
demonstrated that the degree of generation of cyclo—
phenylalanyl—phenylalanine varied ing on the type of the
enzyme and that there was a tendency that a larger amount of
the diketopiperazine was generated by the use of the protease
derived from Bacillus sp.
(Example 4) Production (1) of diketopiperazine from
plant
As a plant, first—grade tea leaves (species: Yabukita,
total nitrogen content: 6.3%) produced in Kagoshima—ken were
used. The tea leaves were first ted to pre—treatment
(pre—extraction, three times) for reducing the amount of
water—soluble protein. That is, 200 g of boiling water was
added to 10 g of the tea leaves, and the mixture was
appropriately stirred for 5 min for extraction. After the
completion of the extraction, the mixture was filtered through
a 140—mesh filter to collect the extraction residue (used tea
leaves). To the used tea leaves was poured 200 g of boiling
water, and extraction was performed for 5 min. The used tea
leaves were collected and were subjected to tion
ent again, and the used tea leaves were collected.
The tea leaves (used tea leaves) after the pre—
extraction were subjected to decomposition treatment with an
enzyme. To the used tea leaves (the whole quantity) was
poured 200 g of hot water of 50°C, and l g of protease (trade
-44_
name: Protin NYlOO, manufactured by Daiwa Fine Chemicals Co.,
Ltd.) was added thereto. The mixture was reacted in a water
bath of 55°C for 3 hours with stirring with a stirring bar
(300 rpm) and was then maintained at 95°C for 30 min to
inactivate the enzyme.
This enzyme—treated solution was subjected to heat
ent in the form of a tea leaf—liquid mixture without
performing solid—liquid separation. The heat treatment was
performed by a high—temperature and high—pressure fluid at
135°C for 3 hours in an autoclave (manufactured by Tomy Seiko
Co., Ltd.). The solution after the treatment was filtered
through a l40emesh filter to obtain a tea extract (extract A).
This tea extract (extract A) (Bx: 0.99) was ed for the
diketopiperazines as in e 1.
Table 4 shows the results. It was demonstrated that
a tea extract including a high concentration of a plant
extract containing a high concentration of diketopiperazines
can be conveniently produced by subjecting tea leaves (used
tea leaves) to high—temperature and highepressure ent in
a liquid. In addition, it was suggested that it is possible
to increase the amount of at least one diketopiperazine
ed from the group consisting of Cyclo (Ala—Gln), Cyclo
(His—Pro), Cyclo (Ala—Ala), Cyclo (Gly-Pro), Cyclo (Ser~Tyr),
Cyclo hr), Cyclo (His—Phe), Cyclo ro), Cyclo (Phe—
Ser), Cyclo (Gly-Leu), Cyclo (Gly—Phe), Cyclo (Pro-Pro), Cyclo
(Gly—Trp), Cyclo (Asp—Phe), Cyclo (Val—Pro), Cyclo (Pro—Tyr),
Cyclo (Met—Pro), Cyclo (Met—Met), Cyclo (Val—Val), Cyclo (Leu—
Pro), Cyclo (Trp—Tyr), Cyclo (Phe—Pro), Cyclo (Leu—Trp), Cyclo
_45..
(Phe—Trp), Cyclo he), Cyclo (Leu—Leu), and Cyclo (Phe—
Phe. In particular, cyclo-leucyl—leucine and cyclo—leucyl—
phenylalanine were contained at high concentrations. The
content of these piperazines was 27.2% in the plant
extract containing them at a high concentration. In the
sensory evaluation of taste, this tea extract was
substantially tasteless and odorless.
-46..
[Table 4]
Diketopipera21ne Extract A
concentration (ppm/Bx)
Cyclo(Ala—Gln) 6.7
Cyclo(His—Pro) 3.5
Ala—Ala) 11.3
Cyclo(Gly—Pro) 3.
Cyclo(Ser—Tyr) 8.
Cyclo(Pro—Thr) 6.
Cyclo(His—Phe) 4.
Cyclo(Ala—Pro) 3.
Phe—Ser) 7.
Cyclo(Gly—Leu) 9.
Cyclo(Gly—Phe) 5.
___,
Pro—Pro) 1.
Cyclo(Gly—Trp) 2.
Cyclo(Asp-Phe) 7
Cyclo(Val—Pro) 2
Cyclo ( Pro—Tyr) 1
Cyclo(Met—Pro) 0.
Cyclo(Met—Met)t 0.
Cyclo(Val—Val 1.
Cyclo{Leu-Pro 6.
Cyclo(Trp—Tyr 1.
Cyclo(Phe—Pro) 1.
Cyclo(Leu—Trp 2.
Cyclo(Phe—Trp 0. JCDF-‘UWKOCDKOP—‘hflwOI-JNOQKOW
Cyclo(Leu—Phe 17.5
Cyclo(Leu—Leu 21.5
Cyclo(Phe—Phe 4.2
Total concentration
143.3
(ppm/Bx)
Total concentration
per unit Bx 14326
(ug/lOOg/Bx)
(Example 5) Production (2) of diketopiperazine from
plant
Commercially available soybean boiled in water and malt
were used as plants. The soybean boiled in water and malt
-47_
were each subjected to pre—extraction, three times, with
boiling water in an amount of 20 times the dry weight of the
plant an), as in Example 4, and were then subjected to
enzyme treatment and high—temperature and high—pressure
treatment in a liquid, as in Example 3, to prepare a soybean
extract (extract B) and a malt extract ct C). The dry
weight of the n was assumed as 36.5% of the total amount
of the soybean boiled in water, based on the data of the Food
Composition Table, 5th ed. The Bx of each of the extract B
and the extract C was adjusted to l, and each extract was then
analyzed for the diketopiperazines as in Example 1. Table 5
shows the results. It was demonstrated that plant extracts
containing high concentrations of diketopiperazines can also
be conveniently produced from soybean and malt.
— 48
[Table 5]
Diketopiperazine
Extract B Extract C
concentration (ppm/BX)
Cyclo(Ala—Gln) (I! O M
Cyclo(His—Pro) NU)
Cyclo(Ala—Ala
Gly—Pro
Cyclo(Ser—Tyr
Cyclo(Pro-Thr
His-Phe
Cyclo(Ala—Pro
Cyclo(Phe—Ser
Cyclo(Gly—Leu)
Cyclo(Gly—Phe
Cyclo(Pro—Pro)
Cyclo Gly—Trp( )
Cyclo Asp—Phe( )
Cyclo(Val— Pro)
Cyclo ( Pro-Tyr)
Cyclo Met— Pro){
Cyclo(Met—Met)t ONwONHOOHHmHomrb-Ni—‘LUO‘XKOWOWW mflwmmfiwmeQE—‘w‘btfiCDKOQOOfiOl-‘N
“Wm-1’7 19.. 6
l\) as. l\)
.2 [\DKOQOHWOONOOOl—‘l—‘bOOMANNN‘bUJNOO wmqwkowm¢QJ>wasqqmwQI—lmwwommmo
‘Total concentration
125.5 79.4
(ppm/BX)
Total concentration
per unit Bx 12553 7936
(ug/lOOg/Bx)
(Example 6) Production (3) of piperazine from
plant
The same tea leaves as those in Example 4 were used as
the plant, and the influence of pre—extraction, enzyme
_49_
treatment, and heat treatment thereon were ed. The
s are shown in Table 6. The samples of sample Nos. 5
and 6 show that the step of generating oligopeptides from a
plant and the step of generating dipeptides through
cyclization of oligopeptides by high—temperature and high—
pressure treatment in a liquid were simultaneously performed
by heat treatment. The pre-extraction was performed as in
Example 4 except that the number of times was two. The enzyme
treatment was performed as in Example 4 except that the
reaction temperature was 50°C. The heat treatment was also
performed as in e 4 except that the heating time was
changed to 8 hours. The ing tea extracts (sample Nos. 1
to 8) were ed by LC~MS/MS as in Example 1.
[Table 6]
Pre—
Step (a) Step (b)
extraction
Not done
Not done
Done Without. heat
Not done With enzyme treatment
Done treatment
Not done Without enzyme treatment,
with heat treatment
Done
(135°C, 8hr)
Not done With heat
W'th
treatment
D trea:;:zie one
(135°C, 8hr)
Table 7 shows the results. It was revealed that
diketopiperazines are not generated if the high—temperature
and ressure treatment in a liquid is not performed
(sample Nos. 1 to 4). In addition, comparison of the samples
of sample Nos. 5 to 8 gave the following findings:
The pre—treatment (extraction treatment) increases the
_50_
diketopiperazine concentration in the resulting tea extract;
Although oligopeptides can be prepared by any of the heat
ent and the enzyme treatment, the enzyme treatment was
more effective and ent.
A plant extract (tea extract) containing a
considerably large total amount of diketopiperazines per Bx,
such as 900 ug/lOO g/Bx or more, was prepared by appropriately
performing pre-extraction, heat treatment, and enzyme
treatment. This suggests that the present invention is
advantageous for a plant extract containing a high
tration of diketopiperazines and production thereof. In
addition, it was suggested that a plant extract (tea extract)
containing each of Cyclo ln), Cyclo (His—Pro), Cyclo
(Ala—Ala), Cyclo (Gly—Pro), Cyclo (Ser—Tyr), Cyclo (Pro—Thr),
Cyclo (His—Phe), Cyclo (Ala—Pro), Cyclo (Phe~Ser), Cyclo (Gly—
Leu), Cyclo (Gly—Phe), Cyclo (Pro—Pro), Cyclo (Asp—Phe), Cyclo
(Val—Pro), Cyclo (Pro—Tyr), Cyclo (Met—Pro), Cyclo (Len—Pro),
Cyclo (Phe—Pro), Cyclo (Leu—Phe), and Cyclo (Leu~Leu) at a
concentration of 10 ug/lOO g/Bx or more can be prepared. It
was suggested that the present invention is also useful for
the production of one or more of these diketopiperazines.
Furthermore, Cyclo(Phe~Phe) was generated by
performing eatment or enzyme treatment. This suggested
that the present invention can provide a plant extract (tea
t) containing Cyclo(Phe—Phe) at a content per Bx of
ug/lOO g/BX or more. Highly hydrophobic Cyclo(Phe—Phe) was
stably retained in the extract (in an aqueous solution).
_51_
Evaluation of the samples of sample Nos. 5 to 8 for
flavor trated that the extracts themselves do not have
any taste such as bitterness. Aqueous solutions containing
one of or all three of Leu-Pro), Cyclo<Phe—Pro), and
Cyclo(Leu—Trp) at the same concentrations as those of the
samples of sample No. 5 were prepared and were evaluated for
flavor. In these solutions, since bitterness was
significantly sensed, it was suggested that the presence of
the diketopiperazines in a tea extract reduces bitterness.
[Table 7]
Diketopiperazine
No.1 No.2 No.3 No.4 No.5
concentration x) i.Ado.)No.6 No.7
Cyclo<Ala—Gln) O O
Cyclo(His—Pro) O O
Cyclo(Ala—Ala >
Cyclo(Gly—Pro )
l Cyclo(Ser—Tyr )
Cyclo(Pro—Thr)
Cyclo(His—Phe)
Cyclo(Ala—Pro )
Cyclo(Phe—Ser)
Cyclo(Gly*Leu )
Cyclo(Gly—Phe)
Cyclo(Pro—Pro)
Cyclo(Gly—Trp )
Cyclo Asp-Phe ) O1000OOOOOOOOOO OONOOONOLOOi—‘i—J ..........
Cyclo(Val-Pro) OOOOOOOOOOOOOOQOO OOOOOOOOOOOOOOOOOO }_\ ' meNmmqomu—Imw
Cyclo(Pro—Tyr) o . n .
Cyclo<Met—Pro) . . . . o
Cyclo(Met—Met)t i
Cyclo Val—Val(
Cyclo (
Cyclo(Trp Tyr .
Cyclo(Phe~Pro
Cyclo ( OW‘l'mLUfiWHWOOLUQmmCOKOLbQWNUWUTCOWKO
Cyclo(Phe—Trp ONHHOWF—‘OOF—‘WONNHU‘IKDQWWONQJW WKOmObeLbGth-NKOKDQN
Cyclo(Leu—Phe OOOOOOO OOOOOOOOOOOOOOOOOOOOOOOOGOO 000000000 000000000 OOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOOi—‘OOOl—‘O ONHOOHOKOOONwUWF—‘OMNNN\lNWWOOLD-P—‘N 'EEEOOOONO I—AusaoomOe-O Omsk-COOOWOOOOHHOOHWWHD—‘(fltfll—Jtfii—‘I—J i GNNr—‘N 16.5
r Cyclo(LeunLeu 20.9
Cyclo(Phe—Phe 3.9
Total concentration
(ppm/BX)
Total concentration
per unit Bx
(pg/:OOg/Bx)
(Example 7) Production (4) of piperazine from
plant
Since the ness of pre-extraction was confirmed in
Example 6, the number of times of the pre—extraction was
examined. First—grade tea leaves (species: Yabukita, total
-53_
nitrogen content: 6.3%) produced in Kagoshima—ken were used as
the plant. In order to achieve a higher concentration of
diketopiperazines, the optimum number of times of pre—
extraction was investigated. The pre~extraction was performed
by the following ure. That is, 200 g of boiling water
was added to 10 g of tea , and the mixture was
appropriately stirred for 5 min for tion. After the
completion of the extraction, the mixture was filtered through
a l40—mesh filter, and the extract was discarded. In the
level of performing the pre-extraction twice or more, 200 g of
boiling water was added again to the used tea leaves collected
by filtration, and the same procedure was repeated. To the
used tea leaves al amount: 10 g) thus subjected to the
pre-treatment from zero to three times, 200 g of hot water of
50°C was poured, and l g of an enzyme protease (Amano Enzyme
Inc., Protin NYlOO) was added o. The mixture was
reacted in a water bath of 50°C for 3 hours with stirring with
a stirring bar (300 rpm) and was then maintained at 95°C for
min to inactivate the enzyme. The resulting tea leaf~
liquid mixture was placed in an ave (Tomy Seiko Co.,
Ltd.) and was subjected to high—temperature and high-pressure
treatment at 135°C for 8 hours, and the resulting solution was
filtered through a l40—mesh filter to prepare a tea extract.
The Bx of each of the resulting extracts was measured, and the
concentration of diketopiperazines was then quantitatively
measured by MS as in Example 1.
Table 8 shows the results. The amount of generated
diketopiperazines increased with the number of times of pre—
_54_
extraction. Fig. 3 shows a onship between the number of
times of pre—extraction and the removal rate of the soluble
component. The removal rate of the soluble component was
calculated by the expression: "(the amount (total amount: g)
of solution obtained by pre-extraction x its Brix [Bx])/(the
amount (g) of solution obtained by repeating ten times the
tion of a plant with boiling water in an amount of 30
times the weight of the plant for 10 min x its Brix [Bx]) x
lOO(%)". It was revealed that 95% or more of the soluble
component can be removed by repeating pre—extraction three
times.
-55_
[Table 8]
. . . The number of times of pre—
Diketopipera21ne
extraction.
concentration
(ppm/Bx) zero once twice tnree
times
Ala—Gln) 1.9 5.0 6.6 6.7
{ Cyclo(His—Pro) 1.3 2.8 3.4 3.5
Cyclo(Ala—Ala) 5.8 9.6 11.9 11.3
Cyclo(Gly—Pro 1.5 2.7 3.2 3.3
Cyclo(Ser~Tyr 3.5 7.0 8.7 8.9
Cyclo(Pro—Thr 3.2 5.8 6.9 6.9
r_ His~Phe 1.3 3.0 3.9 L 4.0
Ala—Pro 1.7 2.7 3.2 L___3.2
Cyclo(Phe—Ser) 3.4 6.7 7.4 7.1
Cyclo(Gly—Leu 3.9 8.6 9.6 9.0
Gly—Phe) 1.8 4.5 5.4 5.3
Cyclo(Pro—Pro 0.8 1.5 .L_l'7 1.7
Cyclo(Gly—Trp> 0.6 1.8 2.4 2.4
Cyclo(Asp—Phe) 1.7 5.2 6.4 7.1
cyclowal—Prm 1-3
Cyclowro-Tym m—
Cyclo(Met—Pro) 0.3 0.7 0.9 0.9
Cyclo(Met-Met)t 0.1 0.0 0.5
Cyclo(Val~Val) 0.3 0.8 1.1 1.1
Cyclo(Leu-Pro) 3.4 6.0 6.7
Cyclo(Trp—Tyr) 0.3 0.9 1.3 1.3
Cyclo(Phe—Pro) 0.6 1.1 1.3
Cyclo(Leu—Trp) 0.6 1.7 2.2 2.2
Cyclo(Phe—Trp) 0.2 0.6 0.8
Cyclo(Leu-Phe) 4.1 12.2 16.5
Cyclo(Leu—Leu) 6.2 16.9 20.9 21.5
Cyclo(Phe—Phe) 0.6 2.6 3.9 y 4.2
TOtal concentration
51.1 114.4 141.6
(ppm/BX) ' 143.3
Total concentration
per unit BX 5114 11437 14157
(Hg/lOOg/Bx)
(Example 8) Production (5) of diketopiperazine from
plant
Since the usefulness of enzyme treatment was confirmed in
...56_
Example 6, the type of the enzyme was examined. The enzymes
examined were the following nine types:
<Sample No. 9> Protin NYlOO: protease (endopeptidase)
derived from us amyloliquefaciens,
<Sample No. 10> Thermoase 160: heat—resistant protease
(endopeptidase) derived from Bacillus stearothermophilus,
<Sample No. 11> Thermoase PC1OF: protease (endopeptidase)
derived from Bacillus stearothermophilus,
<Sample No. 12> ProteAX: neutral protease derived from‘
Aspergillus oryzae,
<Sample No. 13> protease M: neutral protease derived from
Ananas comosus,
e No. 14> se P: ne protease derived
from Aspergillus melleus,
<Sample No. 15> protease A: neutral protease derived from
Aspergillus oryzae,
<Sample No. 16> Peptidase R: neutral protease derived
from Rhizopus oryzae, and
<Sample No. 17> Newlase F3G: acid protease
(endopeptidase) derived from Rhizopus niveus.
As a plant, first-grade tea leaves (species: Yabukita,
total nitrogen content: 6.3%) produced in Kagoshima—ken were
used. Each of used tea leaves was prepared from 10 g of the
tea leaves by ming pre—extraction three times as in
Example 6, 200 g of hot water of 55°C (70°C for Thermoase 160
and Thermoase PClOF) was poured thereinto, and 1 g of an
enzyme was then added thereto. The e was reacted in a
water bath of 55°C (70°C for ase 160 and Thermoase PClOF)
_57_
for 3 hours with stirring with a stirring bar (300 rpm) and
was then maintained at 95°C for 30 min to inactivate the
enzyme. The resulting tea leaf—liquid mixture was placed in
an autoclave (Tomy Seiko Co., Ltd.) and was ted to high—
temperature and high—pressure ent at 135°C for 8 hours,
and the resulting solution was filtered through a 140*mesh
filter to prepare a tea extract. The Bx of each of the
'resulting extracts was measured, and the concentration of
diketopiperazines was then quantitatively measured by LC—MS/MS
as in Example 1.
Table 9 shows the results. It was demonstrated that
the concentration of diketopiperazines icantly increases
by using a bacterial enzyme having a high ptidase
activity. .Among the bacterial enzymes, when neutral protease
derived from Bacillus subtilis and protease derived from
Bacillus stearothermophilus were used, the amount of ted
diketopiperazines particularly increased.
[Table 9]
Diketopiperazine
tration No.9 No.10 No 11 No.12 No.13 No.14 No.15 No.16 No.17
(ppm/Bx)
Cyc;o(Ala—Gln 6.74— 7.0 3.8 2.1 1.3 1.6 l. l. 0.8
Cyc;o(His—Pro 3.5 2.4 2.6 3.2 5.4 4.8 2. 4.2 1.6
.___._—J____
Cyc;o(Ala-Ala) 11.3 9.8 7.5 3.8 2.3 2.7 4. 1.4
Gly..prO 3.3 2.2 1.9 1.2 3.5 2.6 2. 1.6
Cyclo(Ser—Tyr 8.9 5.7 3.5 1.6 0.7 1.3 1. .8
Cyc:_o(Pro—Thr 6.9 5.3 3.8 4.0 7.4 6.8 5. 6.]. 3.7
Cyc:_o(His—Phe 4.0 4.5 3.9 0.5 0.1 0.1 O. 0.3
Cyc;o(Ala-—Pro 3.2 3.2 1.9—1 2.0 3.4 2.7 2. 2.9 1.6
cyc;o(phe_3er 7.1 5.3 4.9 1.5 0.8 1.2 m 0.7
Cyc;o(G1y—Leu 9.0 19.0 10.5 1.3 1.0 1.0 1.3 0.9 0.7
CyclO(Gly_phe 5.3 5.7 5.8 0.8 0.8 1.0 0.6 0.7 0.5
Cyclo(pro_Pro 1.7 1.4 0.7 1.8 1.9 0.6 1.7 .8
———-——————-—————J——.-—————-—-—-
cyaomlyqrp 2.4 2. 0.8 0.4 0.5 0.2
Cyclo<Asp~Phe 7.1 6.4 0.8 1.0 0.7 0.7
Cyc;o(Val—Pro 2.9 1.4 2.0 3.7 3.3 2.6 3.0 1.6
Cyc;o(pro_q;yr 1.8 1.2 1.2 1.3 3.5 2.8 2.7 1.1
Cyc_o(Met—pro) 0.9 0.5 0.7 1.4 0.8 1.0 0.0
cyclo(Met_Met)t 0.5 0.5 0.3 0.0 0.0 0.0 m 0.0 .0
Cyc;o(Va1—Va1) 1.1 1.4 0.7 0.1 0.0 0.1 0. 0.1
cyc;o(Leu_pro) 6.8 4.5 2.5 3.1 6.9 5.5 5.4 5.1 1.9
__._.._—_l
Cyc;o(Trp—Tyr) 1.3 1.5 0.6 0.1 0.0 0.1 0.1 0.0
Cyc; (phe_pro) 1.3 1.0 0.9 1.2 3.2 2.0 2.4 2.4 0.9
CyC;O(Leu-Trp) 2.2 3 4 2.2 0.2 0.1 0.1 0.1 0.1
Cyclo(Phe_Trp) 0.8 0.5 0.0 0.0 0.0 0.0 0.0
Cyc;o(Leu-Phe) 17.5 4.1 10.2 1.1 0.1 0.1 0.1 0.2 0.3
cyc;_o(Leu_Leu) 21.5 8. 10.8 2.6 0.2 0.4 m- 1.
__+___
cyclo(Phe_phe) 4.2 0.8 2.5 0.0 0.0 0.0 mm 0.1
Total
concentration 143.3 112.4 92.9 36.1 49.1 44.7 40.0 40.9 21.9
Total
trat.ion per 14326 11242 9286 3607 4909 4471 4001 4086 2193
unlt Bx
(HQ/loog/BX)
(Exanple 9) Production (6) of diketopiperazine from
plant
Tea extracts were produced as in Example 4 except that
the concentrations of the enzyme (Protin NY100) were changed
-59_
to 0% to 20% based on the amount of the tea leaves. The
resulting tea extracts were subjected to sensory evaluation,
and the contents of 17 types of diketopiperazines shown in
Table 10 were measured by LC-MS/MS as in Example 1 and the
total amount thereof was determined.
Table 10 shows the results. It was suggested that
the enzyme tration should be within a range of 1% to 20%
by weight based on the amount of plant raw material,
preferably 3% to 15% by weight and more preferably 4% to 10%
by weight. In addition, in all of the tea extracts, since the
tea extract itself does not substantially have any taste,
these extracts were judged to be extracts that can be used by
being added to foods and drinks. In particular, the tea
extracts subjected to ations of pre—extraction, enzyme
treatment, and heat treatment had ent flavor.
[Table 10]
Enzyme concentration
Diketooiperazine
RT ‘
. concentration 20%
(min)
( ppm) .1
4 - 4 Cyclo (A1a~Gln . 28 .2
-6 Cyclo(His—Pro 2.4 2.9 4_2
6 - 7 Cyclo(A1a—A1a) 2.2 2.6 ——J3_7
7'4 Gly~Pro 5~9 7-5 10,5
7-8 Cyclo(Ser~Tyr 13.7 13.1
8-1 Cyclo(Pro—”hr 7.5 9.7 9.9 10.7
8-6 Cyc10(His—Phe 0.7 0.9 0.9 1,1
9-2 Cyclo(Ala-—Pro) 0.7 1.0 1.0 1.9
9-6 Cyclo(Phe—Ser 0.4 0.5 0.6 0.8
.2 Cyclo(Gly—Leu 0.2 0.3 0.2 0.3
-2 1.7 1.7 2,2
-7 Cyclo(Pro—Pro 1.6 2.1 2.2 4.0
11 Cyclo(G1y-Trp) 1.4 1.7 1.6 2.2
12. 3 Cyclo(AspPhe)
12. 4 cyclo((Val-_Pro) 11 7 12 9 15. 2 14 8 16. 2 13.3 12.2
12 6 Cyclo((Pro-Tyr) 2 2 2. 8 4.1 4. 6
Total
concentration 79.2 89.9 112.4 113.2 128.8 138.6 130.9 130.5
(ppm)
1....
BX 0.56 0.63 0.79 0.82 0.99
Total 1
concentration
14146 14267 14231 13803 13010 11088
per unit Bx
(ug/lOOg/Bx)
(Example 10) Production (7) of diketopiperazine from
plant
Tea extracts were produced as in Example 4 except that
the conditions for the high—temperature and high—pressure
treatment were changed. Specifically, the same tea leaves as
those in Example 4 were used as the plant at the same amount.
Tea 1eaves (used tea leaves) were ed by repeating pre—
tion with water three times in an amount of 30 times,
d of 20 times, the amount of the plant and were
subjected to enzyme treatment as in Example 4 and to heat
_61_
treatment with the same heat ent ent as that in
Example 4 under the various heating conditions shown in Table
11. The resulting tea extracts were analyzed for the
diketopiperazines in the extracts as in Example 1.
Table 11 shows the results. It was suggested that
generation of diketopiperazines needs heating at 100°C or more
(preferably 115°C or more and more preferably 125°C or more)
for a heating time of about 30 min to 10 hours and preferably
about 2 to 8 hours.
- 62 _
[Table 11]
Heat treatment condition
Diketoconcepntprationi erazine
95°C 105°C 115°C 125°C 135°C
m1nfi 3h 3h 3h 3h
(ppm/Bx)
Cyclo(A1a—G1n)_#_ 0.0 0.8 1.3 2.4 7.6
Cyclo(His— Pro) 0.0 0.5 1.0 1.6 2.2
Cyclo(A1a—A1a) 0.0 3.2 5.8 9.7 19.8
Cyclo(G1y— Pro) 0.0 0.3 0911.6 3.5
} Cyclo(Ser—Tyr) 0.0 0.6 1.3 3.0 5.9
Cyclo(Pro—Thr) 0.2 0.9 1.8 3.2 5.5
Cyclo(His— Phe) 0.0 0.9 1.7 2.5 2.1
Cyclo(A1a— Pro) 0.0 0.8 1.2 2.0
1 4.9
Cyclo(Phe— Ser)_J' 0.1 1.4 1.8 _i_ 2.7 6.9
Cyclo(G1y—Leu) __Jl.0 1.8 4.0 6.3 10.7
Cyclo(G1y— Phe) 0 1 1.7 3.1 5_5.7 9.2
Cyclo(Pro— Pro 0.0 0.1 0.3 0.6 1.6
Cyclo(Gly—Trp) 0.0 0.5 0.8 1.5 3.0
Cyclo<Asp— Phe 0.2 3.1 5.3 9.4 15.5
Cyclo(Val— Pro 0.1 2.1
ProTyr) 0.0 1.4
Cyclo(Ala-Gln 0.0 0.0 0.1 0.3 0.7
Cyclo(His~ Pro 0.0 0.2 0.3 0.4 0.8
Cyclo(Ala—Ala) 0.0 0.1 0.2 0.4 1.6
Cyclo(Gly— Pro 0.3 1.9 3.0 4.2 6.3
Ser—Tyr) 0.0 0.3 0.6 1.1 2.2
Cyclo(Pro—Thr) 0.0 0.0 0.3 0.7 1.4
Cyclo(His— Phe) 0.0 0.5 1.2 2.4 2.7
Ala— Pro) 0.0 0.2 0.1 0.7 1.7
Cyclo(Phe~ Ser) 0.1 1.9 4.7 9.7 14.4
Cyclo(Gly—Leu) 0.2 2.4 5.7 12.0 17.7
Cyclo(G1y— Phe) 0.0 0.7 1.5 2.4 6.0
Total 1.3 25.5 48.9 87.8
tration
(ppm/BX)
Total
Eggcifiiagion 130 2555 4890 8781 15748
(ug/lOOg/Bx)
(Example 11) Production of diketopiperazine~~
containing food or drink
_63__
Tea t A produced in Example 4 and/or water in a
total amount of 50 g as shown in Table 12 was added to 450 g
of a commercially available PET green tea drink to prepare
diketopiperazine—containing tea drinks each in the total
amount of 500 g. These tea drinks were subjected to sensory
evaluation of flavor. The evaluation was performed mainly for
bitterness and judged by overall preference based on five
criteria: very good flavor ((3), good flavor (C3), drinkable
flavor (ll), flavor slightly difficult to drink (X), and
flavor very difficult to drink (XIX).
Table 12 shows the results. It was confirmed that
all of the tea drinks each in an amount of 500 g including 0
to 50 g of the tea extract A containing the diketopiperazine
mixture of Example 4 had good flavor. This suggests that the
tea t prepared by the present invention is a highly
versatile material to be mixed in ing the flavor of
drinks.
[Table 12]
Blending quantity
Total amount of Result of
Water diketopiperazines
tea gree:rin sensory
ex:ea ract amounTotai'
(g) (”g /500 ) evaluation. g
(g) (g) (g)
1 450 L 0 50 500 O
2 450 5 45 500 57 ©
3 450 10 40 500 115 ©
4 450 20 30 500 229 ©
450 30 20 500 1* 344 @
6 450 50 O C)
Claims (9)
1. A plant extract comprising at least one of alanylglutamine , cyclo-alanyl-alanine, cyclo-seryl-tyrosine, cycloglycyl-leucine , cyclo-glycyl-tryptophan, cyclo-valyl-valine, cyclo-tryptophanyl-tyrosine, cyclo-leucyl-tryptophan, cyclophenylalanyl-proline , and cyclo-phenylalanyl-phenylalanine at a concentration of 10 µg/100 g/Bx or more, wherein the plant extract is a tea t, a soybean extract, a barley t, or a sesame extract, and the total amount of diketopiperazine(s) per Bx is 900 µg/100 g/Bx or more.
2. The plant extract according to claim 1, being a tea extract, a soybean extract, or a barley extract.
3. A method for producing a plant extract containing a high concentration of diketopiperazines including cyclo-leucylleucine and cyclo-leucyl-phenylalanine, the method sing a step of subjecting a plant peptide to a treatment at 100°C to 170°C and 0.101 to 0.79 MPa for 30 to 500 minutes in a liquid, wherein the plant peptide is a tea peptide, a soybean peptide, a barley peptide, or a sesame peptide.
4. The method according to claim 3, n the plant peptide is an oligopeptide.
5. The method according to claim 3 or 4, wherein the plant peptide is prepared by subjecting a plant-derived protein or a protein-containing plant to decomposition treatment, wherein the plant is a tea, a soybean, a barley, or a .
6. The method according to claim 5, wherein the decomposition treatment is heat treatment or enzyme treatment.
7. The method according to claim 6, wherein the decomposition treatment is enzyme treatment, and the enzyme is endo-type protease.
8. The plant t of claim 1, substantially as herein described with reference to any one of the Examples and/or Figures f.
9. The method of claim 3, substantially as herein described with reference to any one of the Examples and/or Figures thereof. seas zoEEzwozoo 5:; Amiga g mzmémmaomxa 6554433221109fififififififlfifififififl ,,,,, A B C D E F G H I J Ii UNTREATED ig. 2 9553 2 5m on 2fl 11 5w aimi lnu” mzmémmaomxa AB CDEF (3H E J K UNTREATED /'g. 3 99% 100% 1 0o0/0 mz.<m 90% 29.5.68me 5% 80% ri|._I!L....(LI:Li 75% 2L5 7o% .L: ._<._.O.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013-122259 | 2013-06-10 | ||
JP2013122259 | 2013-06-10 | ||
PCT/JP2014/065388 WO2014200000A1 (en) | 2013-06-10 | 2014-06-10 | Plant extract containing diketopiperazine and method for producing same |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ715250A NZ715250A (en) | 2021-01-29 |
NZ715250B2 true NZ715250B2 (en) | 2021-04-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11382911B2 (en) | Plant extract containing diketopiperazine and method for producing same | |
JP5646035B1 (en) | Method for producing a proteolytic product derived from tea leaves | |
WO2017168718A1 (en) | Packaged beverage | |
KR20190013799A (en) | Composition Containing Caffeine and Cycloalaninyl Alanine | |
JP5645994B2 (en) | Method for producing a proteolytic product derived from tea leaves | |
JP5220813B2 (en) | Taste improving agent for food and drink | |
JP2002179647A (en) | Method for producing nicotianamine or nicotianamine- containing material | |
EP2730176B1 (en) | Taste-improving peptide | |
JP6369951B2 (en) | Dipeptidyl peptidase-IV inhibitor | |
NZ715250B2 (en) | Plant extract containing diketopiperazine and method for producing same | |
Jauregi et al. | Enzymatic processes for the production of food ingredients from food processing by-products | |
JP7182742B1 (en) | Grain tea beverage containing enzymatic decomposition product of sesame protein | |
EP3560345B1 (en) | Food and beverages containing cyclo(aspartyl-glycine), glucose, and maltose | |
CN114277077A (en) | Compound ACE inhibitory peptide with synergistic effect and preparation method and application thereof | |
AU2017381502A1 (en) | Food and beverages containing cyclo(alanyl-serine) and ethanol and/or propylene glycol |